<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Cancer</journal-id><journal-id journal-id-type="publisher-id">cancer</journal-id><journal-id journal-id-type="index">21</journal-id><journal-title>JMIR Cancer</journal-title><abbrev-journal-title>JMIR Cancer</abbrev-journal-title><issn pub-type="epub">2369-1999</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v12i1e79065</article-id><article-id pub-id-type="doi">10.2196/79065</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Information-Seeking Patterns and Communication Preferences Among Japanese Survivors With Cancer: Cross-Sectional Analysis</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Hirayama</surname><given-names>Manae</given-names></name><degrees>MTech</degrees><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="equal-contrib1">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kasai</surname><given-names>Daisuke</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name name-style="western"><surname>Tabei</surname><given-names>Ken-ichi</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="equal-contrib1">*</xref></contrib></contrib-group><aff id="aff1"><institution>Graduate School of Industrial Technology, Advanced Institute of Industrial Technology, Tokyo Metropolitan Public University Corporation</institution><addr-line>1-10-40, Higashiooi</addr-line><addr-line>Shinagawa</addr-line><addr-line>Tokyo</addr-line><country>Japan</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Balcarras</surname><given-names>Matthew</given-names></name></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Cahill</surname><given-names>Naomi</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Lee</surname><given-names>Clara N</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Beltr&#x00E3;o</surname><given-names>Monique</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Ken-ichi Tabei, PhD, Graduate School of Industrial Technology, Advanced Institute of Industrial Technology, Tokyo Metropolitan Public University Corporation, 1-10-40, Higashiooi, Shinagawa, Tokyo, 140-0011, Japan, 81 3 3472 7831; <email>tabei-kenichi@aiit.ac.jp</email></corresp><fn fn-type="equal" id="equal-contrib1"><label>*</label><p>these authors contributed equally</p></fn></author-notes><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>28</day><month>5</month><year>2026</year></pub-date><volume>12</volume><elocation-id>e79065</elocation-id><history><date date-type="received"><day>15</day><month>06</month><year>2025</year></date><date date-type="rev-recd"><day>25</day><month>01</month><year>2026</year></date><date date-type="accepted"><day>26</day><month>01</month><year>2026</year></date></history><copyright-statement>&#x00A9; Manae Hirayama, Daisuke Kasai, Ken-ichi Tabei. Originally published in JMIR Cancer (<ext-link ext-link-type="uri" xlink:href="https://cancer.jmir.org">https://cancer.jmir.org</ext-link>), 28.5.2026. </copyright-statement><copyright-year>2026</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://cancer.jmir.org/">https://cancer.jmir.org/</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://cancer.jmir.org/2026/1/e79065"/><abstract><sec><title>Background</title><p>With increasing numbers of survivors with cancer, the importance of patient-centered information provision and communication to alleviate psychological burdens, such as anxiety and depression, is growing. However, substantial individual differences exist in patients with cancer information&#x2013;seeking behaviors and use of support services, and few studies have comprehensively examined cognitive and psychological factors such as treatment status, sex, trust in information sources, and patient-provider relationships.</p></sec><sec><title>Objective</title><p>This study aimed to integrate the theory of planned behavior and the patient-provider relationship model to identify latent subgroups among Japanese survivors with cancer using information-seeking behaviors, difficulties in information seeking, trust in information sources, and intentions to use psychosocial support services recommended by medical institutions.</p></sec><sec sec-type="methods"><title>Methods</title><p>A CHERRIES (Checklist for Reporting Results of Internet E-Surveys)&#x2013;compliant cross-sectional web survey was conducted in December 2024 with 350 Japanese survivors with cancer (at least 1 year post diagnosis, either undergoing treatment, or within 5 years after completing treatment). Exploratory factor analysis examined items such as difficulties in information seeking, trust in information sources, and assessment of relationships with physicians. Using the resulting factor structure and sociodemographic and clinical characteristics, latent class analysis was conducted. Differences between classes were examined using the chi-square test, Kruskal-Wallis test, and post hoc analyses.</p></sec><sec sec-type="results"><title>Results</title><p>Latent class analysis classified participants into 3 groups: women under observation, men under observation, and patients under treatment. In the women under observation group, evaluation of the reliability of information from nonmedical institutions was significantly higher than in the male group (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=12.30; <italic>P</italic>=.002). Although information-seeking behavior among men under observation was relatively limited, their evaluation of relationships with physicians was significantly higher than that of the treatment group (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=12.20; <italic>P</italic>=.002). The proportion of men who regarded promoting communication with doctors and health care professionals as a benefit of using support services was also significantly higher than that of women (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=12.57; <italic>P</italic>=.002 and Class 2 &#x003E; Class 1; <italic>P</italic>=.001). In the treatment group, searches for information on life during treatment (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=7.22; <italic>P</italic>=.03), use of the Cancer Consultation Support Center (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=17.31; <italic>P</italic>&#x003C;.001), and use of the National Cancer Center website (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=7.59; <italic>P</italic>=.02) were significantly higher than among men under observation. The treatment group also reported greater difficulty in seeking information (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=11.90; <italic>P</italic>=.003).</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Information-seeking behaviors, trusted sources, and perceived difficulties differed by sex and treatment stage among Japanese survivors with cancer. Patients undergoing treatment showed high information needs but greater difficulty in seeking information, suggesting reduced perceived behavioral control. Men under follow-up emphasized relationships with physicians, whereas women relied more on nonmedical information sources. These findings indicate that psychosocial support and information provision should be optimized according to patient-provider communication patterns.</p></sec></abstract><kwd-group><kwd>patient preference</kwd><kwd>latent class analysis</kwd><kwd>survivor with cancer</kwd><kwd>mental health</kwd><kwd>patient-centered communication</kwd><kwd>theory of planned behavior</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Currently, approximately 20 million people worldwide are newly diagnosed with cancer each year [<xref ref-type="bibr" rid="ref1">1</xref>], and this number is expected to reach 35 million by 2050 [<xref ref-type="bibr" rid="ref2">2</xref>]. In Japan, the number of new patients with cancer is projected to reach approximately 4 million between 2035 and 2039 [<xref ref-type="bibr" rid="ref3">3</xref>]. Owing to advances in treatment methods and early detection, many individuals diagnosed with cancer are now long-term survivors, and the number of people classified as survivors with cancer who live with and beyond cancer is increasing [<xref ref-type="bibr" rid="ref4">4</xref>]. Regardless of treatment status, survivors with cancer tend to face various difficulties, including physical, mental, economic, social, and emotional challenges [<xref ref-type="bibr" rid="ref5">5</xref>]. In particular, the prevalence of psychological stress, such as anxiety and depression, is high, making it extremely important to address their emotional needs [<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref>]. Against this background, health care professionals are expected to provide appropriate information and high-quality communication so that patients can confidently make decisions about their diagnosis, prognosis, and treatment options [<xref ref-type="bibr" rid="ref8">8</xref>].</p><p>The most frequently reported unmet nonmedical need among patients with cancer is information [<xref ref-type="bibr" rid="ref9">9</xref>]. Accurate knowledge of the disease and its treatment affects psychological well-being, quality of life, and satisfaction with treatment [<xref ref-type="bibr" rid="ref10">10</xref>]. However, the quality of information, access to it, and the individual&#x2019;s level of understanding pose challenges. Improving the quality of the information provided and accurately identifying patient needs also leads to better communication between patients and physicians [<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref>]. Nonetheless, many survivors with cancer report that the medical terms and explanations used by health care professionals are difficult to understand, resulting in insufficient information and communication [<xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref14">14</xref>]. Therefore, while patient-centered communication [<xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref>]&#x2014;which enhances the reliability of information for survivors with cancer&#x2014;is important, dissatisfaction may not stem solely from a simple lack of communication but may instead be intricately related to individual cognitive and psychological factors, which need to be elucidated.</p><p>Given this background, we conducted a pilot study using content analysis of free-text responses regarding the use of psychosocial support services among survivors with cancer aged 40 years and older [<xref ref-type="bibr" rid="ref17">17</xref>]. The results suggested that factors such as trust in support providers, expectations for emotional regulation, difficulty in verbalizing emotions, a desire for independence, the personality of support providers, clarity of consultation procedures, and awareness and dissemination of services are related to the use of support services [<xref ref-type="bibr" rid="ref17">17</xref>]. These findings suggest that the usage of psychosocial support services may be influenced not only by access and information deficiencies but also by individual cognitive and behavioral characteristics, including personal values. Thus, it is necessary to introduce a theoretical framework to comprehensively and quantitatively capture these complex factors.</p><p>The theory of planned behavior (TPB) has been widely used to explain behavior change among patients with chronic illnesses [<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref>]. According to the TPB, behavioral intention is formed by 3 factors: &#x201C;attitude,&#x201D; &#x201C;subjective norms,&#x201D; and &#x201C;perceived behavioral control&#x201D; [<xref ref-type="bibr" rid="ref20">20</xref>]. However, because the behavior of patients with chronic illnesses is influenced not only by internal cognitive factors but also by external factors such as the living environment, support networks, and health care systems, in this study we integrated external and relational factors, such as the living environment, support networks, and health care systems of survivors with cancer, into the TPB framework to deepen our understanding of the formation of behavioral intentions.</p><p>When addressing communication between patients and health care professionals, which is a central focus of this study, the patient-provider relationship model [<xref ref-type="bibr" rid="ref21">21</xref>] is important. This model explains the impact of the relationship between health care professionals and patients on health outcomes, such as survival, treatment and recovery, relief of symptoms and distress, emotional well-being, and pain control. Communication functions are classified into relationship-oriented functions, which emphasize strengthening the therapeutic relationship and responding to emotions, and task-oriented functions, which involve exchanging information, decision-making, supporting self-management, and managing uncertainty [<xref ref-type="bibr" rid="ref21">21</xref>].</p><p>Previous research has often examined information-seeking behaviors and the use of support services among survivors with cancer on the basis of single attributes, such as treatment phase or sex [<xref ref-type="bibr" rid="ref22">22</xref>-<xref ref-type="bibr" rid="ref24">24</xref>]. There have been limited attempts to comprehensively typify diverse individual behavioral characteristics and psychological factors and theoretically clarify their backgrounds. Therefore, in this study, we aimed to fill this gap by using latent class analysis (LCA) to identify behavioral patterns and by examining the characteristics of these patterns from the perspectives of the TPB and the relationship-oriented and task-oriented functions of the patient-provider relationship model.</p><p>On the basis of the above theoretical framework, we focused on the following two research objectives in this study:</p><list list-type="order"><list-item><p>To identify latent groups that can be typified from the viewpoint of the TPB regarding information-seeking behavior of survivors with cancer, trust in information sources, difficulties faced while seeking information, and use of psychosocial support services.</p></list-item><list-item><p>To examine how the identified latent groups are characterized from the perspectives of the relationship-oriented and task-oriented communication functions of the patient-provider relationship model and to clarify the contextual factors behind information-seeking behaviors and the use of support services.</p></list-item></list></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Research Design</title><p>This cross-sectional survey was conducted on the basis of the CHERRIES (Checklist for Reporting Results of Internet E-Surveys) [<xref ref-type="bibr" rid="ref25">25</xref>] (<xref ref-type="supplementary-material" rid="app3">Checklist 1</xref>).</p><p>The questionnaire, created in Japanese, consisted of 21 screens and 52 items on the website and was designed to be answerable within 25 minutes (<xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>). To prevent missing data, all questions were set as mandatory in the web-based questionnaire. To eliminate duplicate responses, any responses that matched IP address, sex, age, and place of residence were considered to be from the same respondent, and only the first response was included in the analysis.</p><p>Questions regarding patients with cancer information-seeking behavior were developed with reference to previous studies [<xref ref-type="bibr" rid="ref26">26</xref>] that aimed to clarify the information needs and difficulties encountered when searching for information and using psychosocial support services among patients with ovarian cancer, as well as the patient experience survey [<xref ref-type="bibr" rid="ref27">27</xref>] conducted by the National Cancer Center. During development, 3 researchers with experience in medical research and survey studies involving individuals with diseases examined whether each question appropriately reflected the research objectives and theoretical framework from the perspective of content validity and revised the questions for clarity of wording and to minimize respondent burden.</p><p>First, 12 items on sociodemographic information (including sex, age, place of residence, and occupation) and clinical information (including type of cancer, cancer stage, treatment status, and recurrence or metastasis) were collected using a single-choice format during the screening phase. This allowed for the collection of basic attribute information to uniquely classify each respondent. In addition, as a basic indicator related to information seeking, &#x201C;device used to gather information&#x201D; (1 item) was assessed using a single-choice format.</p><p>For information-seeking behavior regarding cancer, we started with the question &#x201C;Have you ever searched for information about cancer?&#x201D; Four multiple-choice checkbox items were used: &#x201C;sources of cancer-related information,&#x201D; &#x201C;social networking service (SNS) or apps used for collecting cancer-related information,&#x201D; and &#x201C;advantages of psychosocial support and information-gathering services recommended by medical institutions.&#x201D; For these questions, mutually exclusive options such as &#x201C;did not search,&#x201D; &#x201C;do not wish to obtain information,&#x201D; &#x201C;do not use SNS or apps,&#x201D; and &#x201C;not applicable&#x201D; were provided to ensure consistency in responses.</p><p>Furthermore, skip logic was introduced: if a respondent answered &#x201C;did not search&#x201D; to the question &#x201C;Have you ever searched for information about cancer?&#x201D; they were not required to answer questions about &#x201C;sources of cancer-related information,&#x201D; &#x201C;devices used to collect information,&#x201D; or &#x201C;SNS or apps used for collecting cancer-related information,&#x201D; and were instead directed straight to the question about &#x201C;difficulties in information seeking.&#x201D; Additionally, even if respondents had searched for information, if they selected either &#x201C;do not wish to obtain information&#x201D; or &#x201C;do not use SNS or apps,&#x201D; they were not asked to answer the question about the &#x201C;device used to gather information.&#x201D;</p><p>For the intention to use psychosocial support and information provision services recommended by medical institutions (corresponding to &#x201C;behavioral intention&#x201D; in the TPB), a yes or no question&#x2014;&#x201C;use of hospital-recommended apps and services for counseling support and information gathering&#x201D;&#x2014;was used (1 item). Only participants who answered &#x201C;Yes&#x201D; were able to proceed to the subsequent question on &#x201C;advantages of psychosocial support and information-gathering services recommended by medical institutions.&#x201D;</p><p>&#x201C;Difficulties in information seeking&#x201D; consisted of 7 items, &#x201C;trusted information sources&#x201D; consisted of 8 items, and &#x201C;evaluation of interpersonal relationships between patients and health care providers&#x201D; consisted of 9 items. To reduce the respondent burden, these were presented in a matrix format and measured using a 5-point Likert scale.</p><p>To assess personality traits, the Japanese version of the 10-Item Personality Inventory (TIPI-J) [<xref ref-type="bibr" rid="ref28">28</xref>], which uses 10 items and a 7-point Likert scale, was used. The TIPI-J measures the Big Five personality dimensions&#x2014;extraversion, agreeableness, conscientiousness, neuroticism, and openness&#x2014;with 2 items each and has shown high internal consistency: extraversion (&#x03B1;=.92), agreeableness (&#x03B1;=.85), conscientiousness (&#x03B1;=.82), neuroticism (&#x03B1;=.91), and openness (&#x03B1;=.86) [<xref ref-type="bibr" rid="ref28">28</xref>]. The TIPI-J has also been shown to be associated with the emotional and cognitive health of patients with brain tumors [<xref ref-type="bibr" rid="ref29">29</xref>], making it a valid indicator for this study.</p><p>To ensure accessibility and usability, a test page simulating the survey environment was created before the actual survey to confirm that the question display and skip logic functioned accurately.</p></sec><sec id="s2-2"><title>Targeting and Survey Distribution</title><p>The survey was conducted privately by Asmarc Inc (a Japanese marketing research company) from December 10 to December 12, 2024. The company operates an online research panel with over 16 million registered members. After agreeing to the membership terms, registered members completed preliminary and final registration, during which they provided basic demographic information, such as age, sex, place of residence, employment status, and medical history.</p><p>The survey was conducted using the D-style web and Monitas platforms (Asmarc Inc) and was conducted using a list of available questionnaires. The eligibility criteria for this study were based on patient-reported outcome criteria for survivors with cancer 1&#x2010;5 years after diagnosis [<xref ref-type="bibr" rid="ref30">30</xref>]. Participants were required to be between 20 and 89 years of age at the time of the survey, to have been diagnosed with cancer at least 1 year prior, and to be either currently undergoing treatment or within 5 years of completing treatment. The following exclusion criteria were applied: participants who reported their treatment status as &#x201C;before cancer treatment&#x201D; or &#x201C;other,&#x201D; those who had been diagnosed with cancer less than 1 year prior, and those for whom more than 10 years had passed since the end of treatment.</p><p>The sample size was calculated using cancer incidence statistics in Japan [<xref ref-type="bibr" rid="ref31">31</xref>] as the reference population. Assuming a 90% CI and a 5% margin of error, the required sample size was estimated to be approximately 270 participants. This calculation was performed using the <italic>pwr</italic> package (version 1.3-0) in R. The <italic>pwr</italic> package was originally developed by St&#x00E9;phane Champely and is currently maintained by Helios De Rosario. Considering a previous recommendation that at least 300 participants are desirable for conducting LCA [<xref ref-type="bibr" rid="ref32">32</xref>], the minimum target sample size for this study was set at 300 participants.</p></sec><sec id="s2-3"><title>Statistical Analysis</title><p>In this study, only data for participants with responses to all questions were included, and statistical analyses were performed using R (version 4.3.2; R Foundation for Statistical Computing). Sociodemographic information was stratified on the basis of the use of psychosocial support services, specifically by responses of &#x201C;Yes&#x201D; or &#x201C;No&#x201D; to &#x201C;use of hospital-recommended apps and services for counseling support and information gathering.&#x201D; Descriptive statistics were calculated for each group. The sociodemographic information included sex, age, place of residence, occupation, and &#x201C;device used to collect cancer information.&#x201D; Cancer-related information consisted of &#x201C;cancer stage,&#x201D; &#x201C;cancer type,&#x201D; &#x201C;presence or absence of recurrence,&#x201D; &#x201C;presence or absence of metastasis,&#x201D; &#x201C;current treatment status,&#x201D; &#x201C;time of cancer diagnosis,&#x201D; and &#x201C;time of cancer treatment completion.&#x201D; Place of residence was recategorized into 6 categories: Hokkaido and Tohoku, Kanto, Chubu, Kinki, Chugoku and Shikoku, and Kyushu and Okinawa. To simplify the classification of cancer types, lung cancer and small cell lung cancer were grouped as lung cancer; esophageal, gastric, small intestine, and colorectal cancers were grouped as gastrointestinal cancer; liver, biliary tract, and pancreatic cancers were grouped as liver, biliary tract, and pancreatic cancer; kidney cancer and cancers of the renal pelvis and ureter and urethra, and bladder cancer were grouped as kidney, ureter, and bladder cancer; ovarian, endometrial, and cervical cancers were grouped as gynecologic cancer; leukemia, malignant lymphoma, and multiple myeloma were grouped as hematologic cancer; and brain tumors, head and neck cancer, thyroid cancer, cancer of unknown primary, skin cancer, and malignant melanoma were grouped as other. For information-seeking behaviors of patients with cancer, descriptive statistics were calculated regarding &#x201C;having searched for information about cancer,&#x201D; &#x201C;sources of cancer information,&#x201D; &#x201C;SNS and apps used to gather cancer information,&#x201D; and &#x201C;benefits of using psychosocial support and information-gathering services recommended by medical institutions.&#x201D; To understand the relational structure among items, analyses were conducted using tetrachoric correlations. Exclusive options such as &#x201C;did not search&#x201D; for &#x201C;having searched for information about cancer,&#x201D; &#x201C;did not want to obtain information&#x201D; for &#x201C;sources of cancer information,&#x201D; &#x201C;do not use SNS or apps&#x201D; for &#x201C;SNS and apps used to gather cancer information,&#x201D; and &#x201C;not applicable&#x201D; for &#x201C;benefits of using psychosocial support and information-gathering services recommended by medical institutions&#x201D; were excluded from the statistical analyses. For the TIPI-J, descriptive statistics were calculated, and the relational structure among the items was examined using polychoric correlations.</p></sec><sec id="s2-4"><title>Structural Validity of the Exploratory Factor Analysis</title><p>Exploratory factor analysis (EFA) was conducted according to the reporting standards proposed by Watkins [<xref ref-type="bibr" rid="ref33">33</xref>]. EFA was chosen to identify the underlying factor structure. The measurement scales used were &#x201C;behavioral barriers experienced when collecting information about cancer,&#x201D; &#x201C;reliable information sources,&#x201D; and &#x201C;relationships with doctors, medical professionals, and society.&#x201D; Each item was rated on a 5-point Likert scale ranging from 1 to 5. The appropriateness of conducting EFA was confirmed using the Bartlett test of sphericity [<xref ref-type="bibr" rid="ref34">34</xref>]. The criteria for determining the number of factors included the Kaiser criterion of eigenvalues greater than 1 [<xref ref-type="bibr" rid="ref35">35</xref>] and the minimum average partial (MAP) method [<xref ref-type="bibr" rid="ref36">36</xref>]. Eigenvalues exceeded 1 up to the fifth factor (fifth factor=1.26), and the MAP exhibited its lowest value (0.03) at the fifth factor; therefore, a 5-factor solution was adopted. To choose the factor extraction method, multivariate normality was examined using the Mardia test [<xref ref-type="bibr" rid="ref37">37</xref>]. Because skewness (skewness=62.14; <italic>P</italic>&#x003C;.01) and kurtosis (kurtosis=613.96; <italic>P</italic>&#x003C;.01) were significant, multivariate normality was rejected, and a method that did not assume normal distribution was required. Moreover, because the items used in this study were ordinal scales based on a 5-point Likert scale, factor analysis using the minimum residual method with a polychoric correlation matrix, which is suitable for ordinal data, was adopted [<xref ref-type="bibr" rid="ref38">38</xref>,<xref ref-type="bibr" rid="ref39">39</xref>]. Oblimin rotation [<xref ref-type="bibr" rid="ref40">40</xref>] was used for simplification and theoretical convergence. Because oblique rotation was used, pattern coefficients of &#x2265;0.37 were judged to be theoretically meaningful loadings, and coefficients of &#x2265;0.40 were considered the primary criterion [<xref ref-type="bibr" rid="ref41">41</xref>] for substantial interpretation. Cross-loadings of &#x2265;0.3 were examined for interpretative caution. Internal consistency was determined using Cronbach &#x03B1; and McDonald &#x03C9;, and factors with a reliability of &#x2265;0.7 [<xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref>] and theoretical significance were judged as appropriate. The analysis was conducted using the <italic>psych</italic> package (version 2.6.2) in R. The <italic>psych</italic> package was developed and is maintained by William Revelle [<xref ref-type="bibr" rid="ref44">44</xref>].</p></sec><sec id="s2-5"><title>The LCA</title><p>In this study, we hypothesized that information-seeking behaviors and the use of psychosocial support services among survivors with cancer are not uniform and that multiple latent profiles exist. To identify these subgroups on the basis of statistical modeling, we used LCA [<xref ref-type="bibr" rid="ref45">45</xref>]. Unlike traditional distance-based cluster analysis, LCA estimates latent structures using probabilistic models, allowing for objective model comparisons using information criteria, making it well suited for identifying latent profiles [<xref ref-type="bibr" rid="ref46">46</xref>]. The analysis followed the reporting standards of Weller et al [<xref ref-type="bibr" rid="ref47">47</xref>], and the optimal number of latent classes was determined on the basis of statistical fit indices and theoretical interpretability [<xref ref-type="bibr" rid="ref48">48</xref>]. For the measurement variables, we recoded variables to ensure estimation stability, categorizing age, occupation, treatment status, and information-gathering devices. To examine the indicators included in the LCA, we conducted a polychoric correlation analysis and included 10 variables&#x2014;sex, age, employment status, cancer type, stage, recurrence, metastasis, treatment status, time since completing treatment, and information-gathering devices&#x2014;which were confirmed to have intervariable correlations of &#x00B1;0.3 or higher. Model fit was assessed primarily using Bayesian information criterion (BIC), adjusted Bayesian information criterion (aBIC), and consistent Akaike information criterion (cAIC), and the model with the smallest value was selected as a candidate. Entropy was checked, with &#x2265;0.8 considered acceptable and &#x2265;0.9 considered ideal [<xref ref-type="bibr" rid="ref48">48</xref>]. For the final model selection, we carefully evaluated whether each class had a sample size of n&#x003E;50 or &#x003E;5% of the total sample and whether each class profile was clinically meaningful. The R <italic>poLCA</italic> package (version 1.6.0.1), developed by Drew A Linzer and Jeffrey B Lewis, was used for the analysis [<xref ref-type="bibr" rid="ref49">49</xref>].</p></sec><sec id="s2-6"><title>Multiple Comparison Tests Between Identified Latent Classes</title><p>We examined the differences in each survey item among the latent classes. The variables compared included &#x201C;counseling support and information gathering through apps and services recommended by the hospital,&#x201D; &#x201C;survey items related to cancer,&#x201D; &#x201C;sources of information about cancer,&#x201D; &#x201C;SNS and apps used to gather cancer information,&#x201D; and &#x201C;advantages of using psychosocial support and information-gathering services recommended by medical institutions,&#x201D; as well as the factors identified in the EFA and the TIPI-J. To assess statistical significance, we adopted nonparametric testing methods with a significance level of <italic>P</italic>&#x003C;.05. For binary items, we used the chi-square test for independence, and for ordinal items, we used the Kruskal-Wallis test. For items where significant differences were observed, we conducted residual analysis for binary items and the Wilcoxon rank-sum test (<italic>P=</italic>.02) for ordinal items as post hoc analyses using the Bonferroni correction and evaluated the association between the latent classes and each survey item.</p></sec><sec id="s2-7"><title>Ethical Considerations</title><p>This study was approved by the Research Safety and Ethics Committee of Tokyo Metropolitan University of Industrial Technology (approval no 23020). The survey was conducted in compliance with the Declaration of Helsinki and relevant ethical guidelines, and only those who provided informed consent participated in the study. The collected data were securely stored in a password-protected database that was accessible solely to the research team. Participants were compensated with reward points according to the regulations of each platform. The allocation and exchange of points were managed exclusively by the survey company, and the research team was not informed about individual point allocations. Participants who responded via the D-style web platform received 2 points for the preliminary survey and 15 points for the main survey, totaling 17 points upon completing both surveys. Participants who responded via the Monitas platform received 2 points for the preliminary survey and 9 points for the main survey, totaling 11 points upon completing both surveys.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><sec id="s3-1"><title>Participant Characteristics</title><p>Of the 4183 members registered on the D-style web and Monitas platforms, 1095 individuals who indicated in their preregistration information that they &#x201C;currently have cancer or have had cancer in the past&#x201D; were selected for the screening survey. Of these, 627 individuals responded (participation rate: 57.3%). Among the respondents, 350 met the eligibility criteria for the main survey and proceeded to participate (transition rate: 55.8%). Accordingly, the final analysis included 350 survivors with cancer (350/1095, 31.9%; <xref ref-type="fig" rid="figure1">Figure 1</xref>).</p><p>The survey participants comprised 175 men and 175 women (175/350, 50%). The average age was 57.9 (SD 10.8) years. The largest age group was 60&#x2010;69 years (138/350, 39.4%), followed by 70&#x2010;79 years (89/350, 25.4%). Regarding occupation, the most common response was unemployed (108/350, 30.9%), followed by company employees (84/350, 24%). Most participants resided in the Kanto region (156/350, 44.6%). Regarding clinical characteristics, the most common types of cancer were breast cancer (93/350, 26.6%) and gastrointestinal cancer (91/350, 26%). Many patients were at an early stage, with stage 1 accounting for 156 of 350 (44.6%) participants. Regarding treatment status, more than half had completed treatment and were undergoing regular follow-up visits at the hospital (202/350, 57.7%). Smartphones (193/350, 55.1%) were the most commonly used devices to gather information about cancer. In contrast, 105 of 350 (30%) participants reported that they did not search for information. Regarding the use of hospital-recommended apps and services for counseling support and information gathering, 282 of 350 (80.6%) participants answered &#x201C;yes,&#x201D; and 68 of 350 (19.4%) participants answered &#x201C;no.&#x201D; Among participants who reported that they did not search for information in response to the question about devices used to gather information about cancer (105/350, 30%), most also reported &#x201C;yes&#x201D; regarding the use of hospital-recommended apps and services for counseling support and information gathering (91/105, 86.7%), with only 14 of 105 (13.3%) reporting &#x201C;no.&#x201D; Of those who answered &#x201C;yes,&#x201D; 161 of 282 (57.1%) had completed treatment and were under regular follow-up, and 72 of 282 (25.5%) were receiving outpatient or home medical care. Smartphones were the most commonly used devices to gather information about cancer (161/282, 46%; <xref ref-type="table" rid="table1">Table 1</xref>).</p><fig position="float" id="figure1"><label>Figure 1.</label><caption><p>Flowchart of participant selection process.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="cancer_v12i1e79065_fig01.png"/></fig><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Patient characteristics (N=350).</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Category</td><td align="left" valign="bottom">Total, n (%)</td><td align="left" valign="bottom">Yes, n (%)</td><td align="left" valign="bottom">No, n (%)</td></tr><tr><td align="left" valign="top" colspan="4">Use of hospital-recommended apps and services for counseling support and information gathering</td></tr></thead><tbody><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sex</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Male</td><td align="left" valign="top">175 (50)</td><td align="left" valign="top">141 (40.3)</td><td align="left" valign="top">34 (9.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Female</td><td align="left" valign="top">175 (50)</td><td align="left" valign="top">141 (40.3)</td><td align="left" valign="top">34 (9.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Age (years)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Mean (SD)</td><td align="left" valign="top" colspan="3">57.9(10.8)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>20&#x2010;29</td><td align="left" valign="top">3 (0.9)</td><td align="left" valign="top">3 (0.9)</td><td align="left" valign="top">0 (0)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>30&#x2010;39</td><td align="left" valign="top">7 (2)</td><td align="left" valign="top">6 (1.7)</td><td align="left" valign="top">1 (0.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>40&#x2010;49</td><td align="left" valign="top">32 (9.14)</td><td align="left" valign="top">28 (8)</td><td align="left" valign="top">4 (1.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>50&#x2010;59</td><td align="left" valign="top">76 (21.7)</td><td align="left" valign="top">56 (16)</td><td align="left" valign="top">20 (5.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>60&#x2010;69</td><td align="left" valign="top">138 (39.4)</td><td align="left" valign="top">114 (32.6)</td><td align="left" valign="top">24 (6.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>70&#x2010;79</td><td align="left" valign="top">89 (25.4)</td><td align="left" valign="top">71 (20.3)</td><td align="left" valign="top">18 (5.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>80&#x2010;89</td><td align="left" valign="top">5 (1.44)</td><td align="left" valign="top">4 (1.14)</td><td align="left" valign="top">1 (0.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Job</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Company employee</td><td align="left" valign="top">84 (24)</td><td align="left" valign="top">73 (20.9)</td><td align="left" valign="top">11 (3.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Civil servant</td><td align="left" valign="top">9 (2.6)</td><td align="left" valign="top">8 (2.3)</td><td align="left" valign="top">1 (0.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Self-employed</td><td align="left" valign="top">21 (6)</td><td align="left" valign="top">18 (5.1)</td><td align="left" valign="top">3 (0.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Company director</td><td align="left" valign="top">6 (1.7)</td><td align="left" valign="top">3 (0.9)</td><td align="left" valign="top">3 (0.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Freelance</td><td align="left" valign="top">6 (1.7)</td><td align="left" valign="top">4 (1.1)</td><td align="left" valign="top">2 (0.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Housewife and househusband</td><td align="left" valign="top">67 (19.1)</td><td align="left" valign="top">48 (13.7)</td><td align="left" valign="top">19 (5.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Part-time job</td><td align="left" valign="top">44 (12.6)</td><td align="left" valign="top">38 (10.9)</td><td align="left" valign="top">6 (1.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unemployed</td><td align="left" valign="top">108 (30.9)</td><td align="left" valign="top">85 (24.3)</td><td align="left" valign="top">23 (6.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other</td><td align="left" valign="top">5 (1.4)</td><td align="left" valign="top">5 (1.4)</td><td align="left" valign="top">0 (0)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Area</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Hokkaido and Tohoku</td><td align="left" valign="top">30 (8.6)</td><td align="left" valign="top">23 (6.6)</td><td align="left" valign="top">7 (2)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Kanto</td><td align="left" valign="top">156 (44.6)</td><td align="left" valign="top">129 (36.9)</td><td align="left" valign="top">27 (7.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Chubu</td><td align="left" valign="top">52 (14.9)</td><td align="left" valign="top">38 (10.9)</td><td align="left" valign="top">14 (4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Kinki</td><td align="left" valign="top">68 (19.4)</td><td align="left" valign="top">53 (15.1)</td><td align="left" valign="top">15 (4.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Chugoku and Shikoku</td><td align="left" valign="top">22 (6.3)</td><td align="left" valign="top">19 (5.5)</td><td align="left" valign="top">2 (0.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Kyushu and Okinawa</td><td align="left" valign="top">22 (6.3)</td><td align="left" valign="top">20 (5.7)</td><td align="left" valign="top">2 (0.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Cancer type</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Lung cancer</td><td align="left" valign="top">29 (8.3)</td><td align="left" valign="top">24 (6.9)</td><td align="left" valign="top">5 (1.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Breast cancer</td><td align="left" valign="top">93 (26.6)</td><td align="left" valign="top">74 (21.1)</td><td align="left" valign="top">19 (5.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Gastrointestinal cancer</td><td align="left" valign="top">91 (26)</td><td align="left" valign="top">74 (21.1)</td><td align="left" valign="top">17 (4.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Liver, biliary tract, and pancreatic cancer</td><td align="left" valign="top">14 (4)</td><td align="left" valign="top">9 (2.6)</td><td align="left" valign="top">5 (1.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Kidney, ureter, and bladder cancer</td><td align="left" valign="top">17 (4.9)</td><td align="left" valign="top">14 (4)</td><td align="left" valign="top">3 (0.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Prostate cancer</td><td align="left" valign="top">39 (11.2)</td><td align="left" valign="top">31 (8.9)</td><td align="left" valign="top">8 (2.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Gynecological cancer</td><td align="left" valign="top">21 (6)</td><td align="left" valign="top">16 (4.6)</td><td align="left" valign="top">5 (1.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Blood cancer</td><td align="left" valign="top">30 (8.6)</td><td align="left" valign="top">27 (7.7)</td><td align="left" valign="top">3 (0.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other</td><td align="left" valign="top">16 (4.6)</td><td align="left" valign="top">13 (3.7)</td><td align="left" valign="top">3 (0.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Stage</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Stage 1</td><td align="left" valign="top">156 (44.6)</td><td align="left" valign="top">129 (36.9)</td><td align="left" valign="top">27 (7.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Stage 2</td><td align="left" valign="top">87 (24.9)</td><td align="left" valign="top">67 (19.1)</td><td align="left" valign="top">20 (5.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Stage 3</td><td align="left" valign="top">68 (19.4)</td><td align="left" valign="top">54 (15.4)</td><td align="left" valign="top">14 (4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Stage 4</td><td align="left" valign="top">39 (11.1)</td><td align="left" valign="top">32 (9.1)</td><td align="left" valign="top">7 (2)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Cancer recurrence</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">62 (17.7)</td><td align="left" valign="top">55 (15.7)</td><td align="left" valign="top">7 (2)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">288 (82.3)</td><td align="left" valign="top">227 (64.9)</td><td align="left" valign="top">61 (17.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Cancer metastasis</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">55 (15.7)</td><td align="left" valign="top">47 (13.4)</td><td align="left" valign="top">8 (2.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">295 (84.3)</td><td align="left" valign="top">235 (67.1)</td><td align="left" valign="top">60 (17.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Current treatment status</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Inpatient treatment</td><td align="left" valign="top">5 (1.4)</td><td align="left" valign="top">5 (1.4)</td><td align="left" valign="top">0 (0)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Outpatient or home visit treatment</td><td align="left" valign="top">87 (24.9)</td><td align="left" valign="top">72 (20.6)</td><td align="left" valign="top">15 (4.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Completed treatment and under regular observation</td><td align="left" valign="top">202 (57.7)</td><td align="left" valign="top">161 (46)</td><td align="left" valign="top">41 (11.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Completed treatment, no hospital visits</td><td align="left" valign="top">56 (16)</td><td align="left" valign="top">44 (12.6)</td><td align="left" valign="top">12 (3.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>When was the cancer diagnosed?</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Within 3 years</td><td align="left" valign="top">127 (36.3)</td><td align="left" valign="top">109 (31.1)</td><td align="left" valign="top">18 (5.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Within 5 years</td><td align="left" valign="top">85 (24.3)</td><td align="left" valign="top">61 (17.4)</td><td align="left" valign="top">24 (6.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Within 10 years</td><td align="left" valign="top">96 (27.4)</td><td align="left" valign="top">75 (21.4)</td><td align="left" valign="top">21 (6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>&#x003E;11 years</td><td align="left" valign="top">42 (12)</td><td align="left" valign="top">37 (10.6)</td><td align="left" valign="top">5 (1.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Time when cancer treatment ended</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>During treatment</td><td align="left" valign="top">58 (16.6)</td><td align="left" valign="top">49 (14.0)</td><td align="left" valign="top">9 (2.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Within 1 year</td><td align="left" valign="top">114 (32.6)</td><td align="left" valign="top">96 (27.4)</td><td align="left" valign="top">18 (5.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Within 3 years</td><td align="left" valign="top">86 (24.6)</td><td align="left" valign="top">60 (17.1)</td><td align="left" valign="top">26 (7.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Within 5 years</td><td align="left" valign="top">92 (26.3)</td><td align="left" valign="top">77 (22.0)</td><td align="left" valign="top">15 (4.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Devices used to gather information about cancer</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Smartphone</td><td align="left" valign="top">193 (55.1)</td><td align="left" valign="top">161 (46.0)</td><td align="left" valign="top">32 (9.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Personal computer</td><td align="left" valign="top">12 (3.4)</td><td align="left" valign="top">10 (2.9)</td><td align="left" valign="top">2 (0.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Tablet (eg, iPad)</td><td align="left" valign="top">8 (2.3)</td><td align="left" valign="top">6 (1.7)</td><td align="left" valign="top">2 (0.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other</td><td align="left" valign="top">32 (9.1)</td><td align="left" valign="top">14 (4)</td><td align="left" valign="top">8 (5.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Not searching for information</td><td align="left" valign="top">105 (30)</td><td align="left" valign="top">91 (26)</td><td align="left" valign="top">14 (4)</td></tr></tbody></table></table-wrap></sec><sec id="s3-2"><title>Information-Seeking Behavior of Patients With Cancer</title><sec id="s3-2-1"><title>Topics Researched Regarding Cancer</title><p>The most frequently researched topic related to cancer was &#x201C;my disease,&#x201D; which accounted for 75.7% (265/350) of responses. This was followed by &#x201C;about treatment&#x201D; (68.6%, 240/350) and &#x201C;progress and prognosis&#x201D; (55.4%, 194/350). &#x201C;Treatment costs&#x201D; accounted for 38.9% (136/350) of responses, &#x201C;life during treatment&#x201D; for 36% (126/350), and &#x201C;other patients&#x2019; treatment and daily life&#x201D; for 27.1% (95/350). Regarding correlations between categories, &#x201C;life during treatment&#x201D; had a strong positive correlation with &#x201C;about my own condition&#x201D; (&#x03C1;=0.7) and &#x201C;progress and prognosis&#x201D; (&#x03C1;=0.64). &#x201C;Other patients&#x2019; treatment and daily life&#x201D; showed a moderate positive correlation with &#x201C;about my own condition&#x201D; (&#x03C1;=0.61).</p></sec><sec id="s3-2-2"><title>Sources of Cancer Information and Use of SNS and Apps</title><p>The most common source of cancer-related information was &#x201C;internet/SNS&#x201D; (58.9%, 206/350), followed by &#x201C;doctors, nurses, and other medical staff&#x201D; (50.6%, 177/350). Other sources included &#x201C;newspapers, magazines, and books&#x201D; (17.7%, 62/350), &#x201C;family, friends, and acquaintances&#x201D; (15.7%, 55/350), &#x201C;National Cancer Center website&#x201D; (15.4%, 54/350), and &#x201C;cancer counseling support center&#x201D; (7.4%, 26/350). Regarding correlations between categories, a moderately strong correlation (&#x03C1;=0.69) was observed between &#x201C;newspapers, magazines, and books&#x201D; and &#x201C;television and radio,&#x201D; Among the SNS and apps used, YouTube (Google LLC) was the most common (13.4%, 47/350), followed by blogs (10%, 35/350), LINE, provided by LY Corporation (7.4%, 26/350), and X (formerly Twitter, provided by X Corp; 6%, 21/350). These items exhibited positive correlations with each other (&#x03C1;=0.48-0.6).</p></sec><sec id="s3-2-3"><title>Benefits of Using Psychosocial Support and Information-Gathering Services Recommended by Health Care Institutions</title><p>The most commonly identified benefits of psychosocial support services or apps were &#x201C;being able to obtain reliable information&#x201D; (59.7%, 209/350) and &#x201C;deepening knowledge about illness and treatment&#x201D; (58.6%, 205/350), with more than half of the respondents emphasizing the quality and understanding of information. &#x201C;Receiving information and support tailored to one&#x2019;s own symptoms or situation&#x201D; was cited by 45.4% (159/350) of patients, and &#x201C;facilitating communication with doctors or medical staff&#x201D; was cited by 29.4% (103/350) of patients. Regarding correlations between items, a strong positive correlation (&#x03C1;=0.71) was found between &#x201C;deepening knowledge about illness and treatment&#x201D; and &#x201C;receiving information suited to one&#x2019;s own symptoms or situation.&#x201D; &#x201C;Easy to operate and user-friendly&#x201D; showed a moderate positive correlation with both &#x201C;deepening knowledge about illness and treatment&#x201D; (&#x03C1;=0.61) and &#x201C;facilitating communication with doctors or medical staff&#x201D; (&#x03C1;=0.6; <xref ref-type="table" rid="table2">Table 2</xref> and <xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref>).</p><table-wrap id="t2" position="float"><label>Table 2.</label><caption><p>Trends in information-seeking behavior among patients with cancer.</p></caption><table id="table2" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Item</td><td align="left" valign="bottom">Value, n (%)</td></tr></thead><tbody><tr><td align="left" valign="top" colspan="2">Things I have researched about cancer</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>About treatment</td><td align="left" valign="top">240 (68.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>My disease</td><td align="left" valign="top">265 (75.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Course or prognosis</td><td align="left" valign="top">194 (55.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Information about other patients</td><td align="left" valign="top">95 (27.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Life during treatment</td><td align="left" valign="top">126 (36)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Cost of treatment</td><td align="left" valign="top">136 (38.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other</td><td align="left" valign="top">20 (5.7)</td></tr><tr><td align="left" valign="top" colspan="2">Sources of cancer information</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Cancer Consultation Support Center</td><td align="left" valign="top">26 (7.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Doctors, nurses, and so on</td><td align="left" valign="top">177 (50.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Contact at public health center or health center</td><td align="left" valign="top">5 (1.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Newspapers, magazines, and books</td><td align="left" valign="top">62 (17.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Television and radio</td><td align="left" valign="top">40 (11.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>National Cancer Center website</td><td align="left" valign="top">54 (15.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Internet and SNS<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup></td><td align="left" valign="top">206 (58.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Family, friends, and acquaintances</td><td align="left" valign="top">55 (15.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other</td><td align="left" valign="top">6 (1.7)</td></tr><tr><td align="left" valign="top" colspan="2">SNS and apps used to gather cancer information</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Facebook (Meta Platforms, Inc)</td><td align="left" valign="top">14 (4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Instagram (Meta Platforms, Inc)</td><td align="left" valign="top">15 (4.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>LINE (LY Corporation)</td><td align="left" valign="top">26 (7.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>X (formerly Twitter; X Corp)</td><td align="left" valign="top">21 (6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>YouTube (Google LLC)</td><td align="left" valign="top">47 (13.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Blog</td><td align="left" valign="top">35 (10)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other</td><td align="left" valign="top">46 (13.1)</td></tr><tr><td align="left" valign="top" colspan="2">Benefits of using psychosocial support and information-gathering services recommended by health care institutions</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Access to reliable information</td><td align="left" valign="top">209 (59.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Easy to operate and use</td><td align="left" valign="top">76 (21.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Access to the latest medical information</td><td align="left" valign="top">152 (43.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Easy to understand correct usage and operation</td><td align="left" valign="top">78 (22.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Personal information is kept safe</td><td align="left" valign="top">58 (16.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Facilitate communication with doctors and medical staff</td><td align="left" valign="top">103 (29.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Gain knowledge about illnesses and treatments</td><td align="left" valign="top">205 (58.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Get information and support tailored to your symptoms and situation</td><td align="left" valign="top">159 (45.4)</td></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><p><sup>a</sup>SNS: social networking services.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s3-3"><title>TIPI-J</title><p>The mean scores reported by respondents were highest for neuroticism at 8.62 (SD 2.47), followed by openness at 8.24 (SD 2.43), extraversion at 7.65 (SD 2.6), and conscientiousness at 7.15 (SD 2.29). Agreeableness exhibited the lowest value among the 5 traits, at 5.84 (SD 2.03). A Shapiro-Wilk test [<xref ref-type="bibr" rid="ref50">50</xref>] was conducted to assess the distribution of each scale, and the results were significant for extraversion (W=0.98; <italic>P</italic>&#x003C;.001), agreeableness (W=0.95; <italic>P</italic>&#x003C;.001), conscientiousness (W=0.98; <italic>P</italic>&#x003C;.001), neuroticism (W=0.98; <italic>P</italic>&#x003C;.001), and openness (W=0.98; <italic>P</italic>&#x003C;.001), indicating that the data were not normally distributed. The correlations among the subscales were uniformly low (<italic>r</italic>=&#x2212;0.43 to 0.37; <xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref>).</p></sec><sec id="s3-4"><title>EFA Results</title><p>The Bartlett test of sphericity was conducted to assess the applicability of factor analysis. On the basis of the results, the null hypothesis that the correlation matrix is an identity matrix was rejected (<italic>&#x03C7;</italic>&#x00B2;<sub>210</sub>=5425.91; <italic>P</italic>&#x003C;.001), indicating that there was a sufficiently robust correlation structure among the items. The Kaiser-Meyer-Olkin statistic was 0.81, confirming sampling adequacy and determining that factor analysis was appropriate. The number of factors was determined on the basis of eigenvalues, MAP, and theoretical consistency. Eigenvalues exceeded 1 up to the fifth factor (factor 1=6.33, factor 2=4.27, factor 3=2.56, factor 4=1.86, and factor 5=1.26), and the cumulative contribution of the 5-factor solution was 67.83%. MAP decreased with the addition of more factors and improved up to the fifth factor. In addition to these results, considering that the measurement included several conceptual domains such as &#x201C;difficulties in information seeking,&#x201D; &#x201C;support and consultation for care,&#x201D; &#x201C;relationship with the physician,&#x201D; &#x201C;trust in information from medical institutions and specialized websites,&#x201D; and &#x201C;trust in information from outside medical institutions,&#x201D; a 5-factor solution was adopted.</p><p>Factor 1 included items reflecting difficulties encountered in the process of seeking cancer-related information (factor loadings: 0.54-0.9) and was named &#x201C;difficulties in information seeking.&#x201D; Factor 2 included items related to continued employment before treatment, concerns about appearance, convalescence, precautions in daily life, and workplace considerations (factor loadings: 0.42-0.74) and was interpreted as &#x201C;evaluation of support for cancer care.&#x201D; Factor 3 included items on the primary physician&#x2019;s knowledge and experience, ease of consultation, and trust in information provided by physicians (factor loadings: 0.67-0.81) and was named &#x201C;evaluation of the relationship with the physician.&#x201D; Factor 4 included trust in information from cancer-specialized or hospital or pharmaceutical company websites (factor loadings: 0.73-0.85) and was named &#x201C;evaluation of the reliability of information from medical institutions and cancer-related websites.&#x201D; Factor 5 included trust in sources of information outside medical institutions, such as family and acquaintances, other patients, and social networking sites (factor loadings: 0.47-0.76) and was named &#x201C;assessment of the reliability of information from nonmedical institutions.&#x201D;</p><p>The item &#x201C;I had to visit several websites&#x201D; loaded on both Factor 1 (0.60) and Factor 4 (0.33), and &#x201C;the most reliable source is information from the physician&#x201D; loaded on both Factor 3 (0.67) and Factor 4 (0.32). The internal consistency of the factors ranged from &#x03B1;=.75 to .9 and <italic>&#x03C9;</italic>=0.78 to 0.92, with small interfactor correlations, the highest being between Factors 2 and 3 (<italic>r</italic>=0.47), justifying the treatment of the 5 factors as independent subconcepts (<xref ref-type="table" rid="table3">Table 3</xref>).</p><table-wrap id="t3" position="float"><label>Table 3.</label><caption><p>Factor structure of information-seeking behavior and evaluation of information sources and psychosocial support services among survivors with cancer.</p></caption><table id="table3" frame="hsides" rules="groups"><thead><tr><td align="left" valign="top">Item</td><td align="left" valign="top">Mean (SD)</td><td align="left" valign="top">Skewness</td><td align="left" valign="top">Kurtosis</td><td align="left" valign="top">Factor 1</td><td align="left" valign="top">Factor 2</td><td align="left" valign="top">Factor 3</td><td align="left" valign="top">Factor 4</td><td align="left" valign="top">Factor 5</td><td align="left" valign="top">H&#x00B2;</td></tr></thead><tbody><tr><td align="left" valign="top" colspan="10">Factor 1: difficulties in information seeking</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I didn&#x2019;t know where to look for it</td><td align="left" valign="top">2.88 (1.18)</td><td align="left" valign="top">0.08</td><td align="left" valign="top">&#x2212;1.01</td><td align="left" valign="top">0.9</td><td align="left" valign="top">0.1</td><td align="left" valign="top">0</td><td align="left" valign="top">&#x2212;0.15</td><td align="left" valign="top">0.01</td><td align="left" valign="top">0.82</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I didn&#x2019;t know who to ask</td><td align="left" valign="top">2.81 (1.18)</td><td align="left" valign="top">0.15</td><td align="left" valign="top">&#x2212;1.03</td><td align="left" valign="top">0.88</td><td align="left" valign="top">0.04</td><td align="left" valign="top">&#x2212;0.04</td><td align="left" valign="top">&#x2212;0.09</td><td align="left" valign="top">0.05</td><td align="left" valign="top">0.8</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I didn&#x2019;t know what to look for</td><td align="left" valign="top">2.92 (1.17)</td><td align="left" valign="top">0.13</td><td align="left" valign="top">&#x2212;0.96</td><td align="left" valign="top">0.88</td><td align="left" valign="top">0.05</td><td align="left" valign="top">0.03</td><td align="left" valign="top">&#x2212;0.23</td><td align="left" valign="top">0.04</td><td align="left" valign="top">0.81</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I couldn&#x2019;t find the information I wanted right away</td><td align="left" valign="top">3.11 (1.14)</td><td align="left" valign="top">&#x2212;0.16</td><td align="left" valign="top">&#x2212;0.9</td><td align="left" valign="top">0.77</td><td align="left" valign="top">&#x2212;0.01</td><td align="left" valign="top">0</td><td align="left" valign="top">0.12</td><td align="left" valign="top">&#x2212;0.12</td><td align="left" valign="top">0.61</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I didn&#x2019;t know which information I could trust</td><td align="left" valign="top">3.04 (1.08)</td><td align="left" valign="top">&#x2212;0.07</td><td align="left" valign="top">&#x2212;0.8</td><td align="left" valign="top">0.71</td><td align="left" valign="top">&#x2212;0.09</td><td align="left" valign="top">0.07</td><td align="left" valign="top">&#x2212;0.01</td><td align="left" valign="top">0.05</td><td align="left" valign="top">0.51</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I had to go to several websites</td><td align="left" valign="top">3.31 (1.09)</td><td align="left" valign="top">&#x2212;0.43</td><td align="left" valign="top">&#x2212;0.64</td><td align="left" valign="top">0.6</td><td align="left" valign="top">0</td><td align="left" valign="top">&#x2212;0.04</td><td align="left" valign="top">0.33</td><td align="left" valign="top">&#x2212;0.03</td><td align="left" valign="top">0.47</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I couldn&#x2019;t ask the doctor a question</td><td align="left" valign="top">2.25 (1.12)</td><td align="left" valign="top">0.73</td><td align="left" valign="top">&#x2212;0.28</td><td align="left" valign="top">0.54</td><td align="left" valign="top">&#x2212;0.1</td><td align="left" valign="top">&#x2212;0.39</td><td align="left" valign="top">&#x2212;0.01</td><td align="left" valign="top">0.06</td><td align="left" valign="top">0.57</td></tr><tr><td align="left" valign="top" colspan="10">Factor 2: support and consultation for care</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I think a medical professional spoke to me about continuing to work before starting treatment</td><td align="left" valign="top">3.15 (1.1)</td><td align="left" valign="top">&#x2212;0.2</td><td align="left" valign="top">&#x2212;0.54</td><td align="left" valign="top">&#x2212;0.02</td><td align="left" valign="top">0.74</td><td align="left" valign="top">&#x2212;0.06</td><td align="left" valign="top">0.1</td><td align="left" valign="top">0.02</td><td align="left" valign="top">0.55</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I felt I could talk to a medical professional about my concerns about changes in appearance</td><td align="left" valign="top">3.07 (1)</td><td align="left" valign="top">&#x2212;0.1</td><td align="left" valign="top">&#x2212;0.31</td><td align="left" valign="top">0</td><td align="left" valign="top">0.73</td><td align="left" valign="top">&#x2212;0.06</td><td align="left" valign="top">0.03</td><td align="left" valign="top">0.04</td><td align="left" valign="top">0.51</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I think I was able to talk to someone about my illness and medical treatment</td><td align="left" valign="top">3.27 (0.97)</td><td align="left" valign="top">&#x2212;0.24</td><td align="left" valign="top">&#x2212;0.4</td><td align="left" valign="top">0.05</td><td align="left" valign="top">0.71</td><td align="left" valign="top">0.13</td><td align="left" valign="top">&#x2212;0.03</td><td align="left" valign="top">&#x2212;0.01</td><td align="left" valign="top">0.59</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent"/>I think there were medical professionals other than my primary care physician whom I felt comfortable talking to.</td><td align="left" valign="top">3.58 (0.93)</td><td align="left" valign="top">&#x2212;0.54</td><td align="left" valign="top">0.14</td><td align="left" valign="top">&#x2212;0.04</td><td align="left" valign="top">0.62</td><td align="left" valign="top">0.29</td><td align="left" valign="top">0.06</td><td align="left" valign="top">&#x2212;0.06</td><td align="left" valign="top">0.66</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I think my workplace and work colleagues have made arrangements to allow me to continue both my treatment and work</td><td align="left" valign="top">3.02 (1.13)</td><td align="left" valign="top">&#x2212;0.1</td><td align="left" valign="top">&#x2212;0.55</td><td align="left" valign="top">&#x2212;0.01</td><td align="left" valign="top">0.5</td><td align="left" valign="top">&#x2212;0.09</td><td align="left" valign="top">0.08</td><td align="left" valign="top">0.08</td><td align="left" valign="top">0.26</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I think I was able to get information from medical professionals about important points to keep in mind in daily life</td><td align="left" valign="top">3.38 (1.01)</td><td align="left" valign="top">&#x2212;0.23</td><td align="left" valign="top">&#x2212;0.66</td><td align="left" valign="top">0.03</td><td align="left" valign="top">0.48</td><td align="left" valign="top">0.17</td><td align="left" valign="top">&#x2212;0.1</td><td align="left" valign="top">&#x2212;0.09</td><td align="left" valign="top">0.31</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I believe information about the patient&#x2019;s treatment was shared among the medical professionals involved in the treatment</td><td align="left" valign="top">3.64 (0.86)</td><td align="left" valign="top">&#x2212;0.34</td><td align="left" valign="top">&#x2212;0.11</td><td align="left" valign="top">0.02</td><td align="left" valign="top">0.42</td><td align="left" valign="top">0.41</td><td align="left" valign="top">0.03</td><td align="left" valign="top">&#x2212;0.02</td><td align="left" valign="top">0.51</td></tr><tr><td align="left" valign="top" colspan="10">Factor 3: relationship with the physician</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>The primary physician has sufficient knowledge and experience about the patient&#x2019;s cancer.</td><td align="left" valign="top">4.11 (0.88)</td><td align="left" valign="top">&#x2212;0.9</td><td align="left" valign="top">0.43</td><td align="left" valign="top">&#x2212;0.07</td><td align="left" valign="top">0.08</td><td align="left" valign="top">0.81</td><td align="left" valign="top">0.08</td><td align="left" valign="top">0.01</td><td align="left" valign="top">0.79</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>I think the primary physician who treated my cancer was easy to talk to.</td><td align="left" valign="top">3.97 (1)</td><td align="left" valign="top">&#x2212;1.03</td><td align="left" valign="top">0.71</td><td align="left" valign="top">&#x2212;0.05</td><td align="left" valign="top">0.16</td><td align="left" valign="top">0.8</td><td align="left" valign="top">&#x2212;0.09</td><td align="left" valign="top">0.06</td><td align="left" valign="top">0.77</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>A reliable source of information is a doctor's information.</td><td align="left" valign="top">4.21 (0.77)</td><td align="left" valign="top">&#x2212;0.94</td><td align="left" valign="top">1.26</td><td align="left" valign="top">0.03</td><td align="left" valign="top">0</td><td align="left" valign="top">0.67</td><td align="left" valign="top">0.32</td><td align="left" valign="top">0</td><td align="left" valign="top">0.64</td></tr><tr><td align="left" valign="top" colspan="10">Factor 4: trust in information from medical institutions and specialized websites</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Reliable sources of information include information from cancer-specific websites such as cancer information services.</td><td align="left" valign="top">3.68 (0.75)</td><td align="left" valign="top">&#x2212;0.54</td><td align="left" valign="top">0.95</td><td align="left" valign="top">0.11</td><td align="left" valign="top">0.11</td><td align="left" valign="top">0.03</td><td align="left" valign="top">0.85</td><td align="left" valign="top">&#x2212;0.01</td><td align="left" valign="top">0.79</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Reliable sources of information include information from hospital websites.</td><td align="left" valign="top">3.63 (0.74)</td><td align="left" valign="top">&#x2212;0.42</td><td align="left" valign="top">0.61</td><td align="left" valign="top">0.03</td><td align="left" valign="top">0.06</td><td align="left" valign="top">0.26</td><td align="left" valign="top">0.75</td><td align="left" valign="top">0.06</td><td align="left" valign="top">0.76</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Reliable sources of information include information from pharmaceutical company websites.</td><td align="left" valign="top">3.29 (0.74)</td><td align="left" valign="top">&#x2212;0.18</td><td align="left" valign="top">0.71</td><td align="left" valign="top">&#x2212;0.04</td><td align="left" valign="top">0.13</td><td align="left" valign="top">0.01</td><td align="left" valign="top">0.73</td><td align="left" valign="top">0.09</td><td align="left" valign="top">0.63</td></tr><tr><td align="left" valign="top" colspan="10">Factor 5: trust in information from outside medical institutions</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Reliable sources of information include exchanging information with family and acquaintances.</td><td align="left" valign="top">2.99 (0.74)</td><td align="left" valign="top">&#x2212;0.1</td><td align="left" valign="top">0.76</td><td align="left" valign="top">0</td><td align="left" valign="top">0</td><td align="left" valign="top">0.2</td><td align="left" valign="top">&#x2212;0.12</td><td align="left" valign="top">0.76</td><td align="left" valign="top">0.57</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Reliable sources of information include information shared among patients.</td><td align="left" valign="top">3.08 (0.76)</td><td align="left" valign="top">0.02</td><td align="left" valign="top">0.72</td><td align="left" valign="top">0.06</td><td align="left" valign="top">&#x2212;0.09</td><td align="left" valign="top">&#x2212;0.01</td><td align="left" valign="top">0.18</td><td align="left" valign="top">0.74</td><td align="left" valign="top">0.62</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Reliable sources of information include information from lectures.</td><td align="left" valign="top">3.04 (0.71)</td><td align="left" valign="top">&#x2212;0.34</td><td align="left" valign="top">1.44</td><td align="left" valign="top">0.05</td><td align="left" valign="top">0</td><td align="left" valign="top">0.01</td><td align="left" valign="top">0.36</td><td align="left" valign="top">0.61</td><td align="left" valign="top">0.58</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Reliable sources of information included social media (Facebook and Instagram [Meta Platforms, Inc], X [formerly Twitter; X Corp], and YouTube [Google LLC]).</td><td align="left" valign="top">2.6 (0.78)</td><td align="left" valign="top">&#x2212;0.45</td><td align="left" valign="top">&#x2212;0.02</td><td align="left" valign="top">&#x2212;0.04</td><td align="left" valign="top">0.1</td><td align="left" valign="top">&#x2212;0.12</td><td align="left" valign="top">&#x2212;0.09</td><td align="left" valign="top">0.47</td><td align="left" valign="top">0.25</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Factor contribution</td><td align="left" valign="top">&#x2014;<sup><xref ref-type="table-fn" rid="table3fn1">a</xref></sup></td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">4.32</td><td align="left" valign="top">4.26</td><td align="left" valign="top">4.03</td><td align="left" valign="top">3.09</td><td align="left" valign="top">2.03</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top" colspan="10">Internal validity</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Crombach &#x03B1;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">0.9</td><td align="left" valign="top">0.84</td><td align="left" valign="top">0.87</td><td align="left" valign="top">0.88</td><td align="left" valign="top">0.75</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Macdonald &#x03C9;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">0.92</td><td align="left" valign="top">0.86</td><td align="left" valign="top">0.89</td><td align="left" valign="top">0.89</td><td align="left" valign="top">0.78</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top" colspan="10">Factor correlation</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Factor 1</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Factor 2</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2212;0.08</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Factor 3</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2212;0.16</td><td align="left" valign="top">0.47</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Factor 4</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">0.01</td><td align="left" valign="top">0.21</td><td align="left" valign="top">0.21</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Factor 5</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">0.04</td><td align="left" valign="top">0.16</td><td align="left" valign="top">&#x2212;0.07</td><td align="left" valign="top">0.18</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td></tr></tbody></table><table-wrap-foot><fn id="table3fn1"><p><sup>a</sup>Not available.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-5"><title>LCA Results</title><p>In determining the number of latent classes, models with 2-6 classes were estimated, and BIC was used as the primary index with comparisons to aBIC and cAIC. The 3-class model had the lowest BIC (5734.74) and cAIC (5805.74) and demonstrated high classification accuracy with an entropy of 0.95. Although the 4-class model had the lowest aBIC (5465) and similarly high entropy (0.96), both BIC and cAIC worsened (BIC=5766.37 and cAIC=5861.37). For models with 5-6 classes, the information criteria further increased, suggesting model overfitting. In finalizing the model, it was confirmed that each class had a sample size of n&#x003E;50 or &#x003E;5% of the total and that the class profiles were clinically interpretable. On the basis of minimum BIC and cAIC values and high classification accuracy, the 3-class model was selected as the final model (<xref ref-type="table" rid="table4">Table 4</xref>).</p><table-wrap id="t4" position="float"><label>Table 4.</label><caption><p>Model selection criteria.</p></caption><table id="table4" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Model</td><td align="left" valign="bottom">Log-likelihood</td><td align="left" valign="bottom">Residual df</td><td align="left" valign="bottom">BIC<sup><xref ref-type="table-fn" rid="table4fn1">a</xref></sup></td><td align="left" valign="bottom">aBIC<sup><xref ref-type="table-fn" rid="table4fn2">b</xref></sup></td><td align="left" valign="bottom">cAIC<sup><xref ref-type="table-fn" rid="table4fn3">c</xref></sup></td><td align="left" valign="bottom">Likelihood ratio</td><td align="left" valign="bottom">Entropy</td></tr></thead><tbody><tr><td align="left" valign="top">Model 1</td><td align="left" valign="top">&#x2014;<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup></td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">Model 2</td><td align="left" valign="top">&#x2212;2778.75</td><td align="left" valign="top">303</td><td align="left" valign="top">5832.82</td><td align="left" valign="top">5683.72</td><td align="left" valign="top">5879.82</td><td align="left" valign="top">1697.5</td><td align="left" valign="top">1</td></tr><tr><td align="left" valign="top">Model 3</td><td align="left" valign="top">&#x2212;2659.41</td><td align="left" valign="top">279</td><td align="left" valign="top">5734.74</td><td align="left" valign="top">5509.5</td><td align="left" valign="top">5805.74</td><td align="left" valign="top">1458.82</td><td align="left" valign="top">0.95</td></tr><tr><td align="left" valign="top">Model 4</td><td align="left" valign="top">&#x2212;2604.93</td><td align="left" valign="top">255</td><td align="left" valign="top">5766.37</td><td align="left" valign="top">5465</td><td align="left" valign="top">5861.37</td><td align="left" valign="top">1349.87</td><td align="left" valign="top">0.96</td></tr><tr><td align="left" valign="top">Model 5</td><td align="left" valign="top">&#x2212;2582.65</td><td align="left" valign="top">231</td><td align="left" valign="top">5862.39</td><td align="left" valign="top">5484.88</td><td align="left" valign="top">5981.39</td><td align="left" valign="top">1305.3</td><td align="left" valign="top">0.94</td></tr><tr><td align="left" valign="top">Model 6</td><td align="left" valign="top">&#x2212;2563.22</td><td align="left" valign="top">207</td><td align="left" valign="top">5964.12</td><td align="left" valign="top">5510.47</td><td align="left" valign="top">6107.12</td><td align="left" valign="top">1266.43</td><td align="left" valign="top">0.94</td></tr></tbody></table><table-wrap-foot><fn id="table4fn1"><p><sup>a</sup>BIC: Bayesian information criterion.</p></fn><fn id="table4fn2"><p><sup>b</sup>aBIC: adjusted Bayesian information criterion.</p></fn><fn id="table4fn3"><p><sup>c</sup>cAIC: consistent Akaike information criterion.</p></fn><fn id="table4fn4"><p><sup>d</sup>Not available.</p></fn></table-wrap-foot></table-wrap><p>After fitting the model, the results for the 3 classes identified by the LCA were as follows. Class 1 comprised 95 individuals, all of whom were female (95/95, 100%). Most patients in Class 1 were between the ages of 50 and 69 years, with 35 of 95 (36.8%) aged 50&#x2010;59 years and 31 of 95 (32.6%) aged 60&#x2010;69 years. Regarding treatment status, 74 of 95 (77.9%) patients were undergoing regular follow-up after completing treatment, while 21 of 95 (22.1%) were in the follow-up stage without needing to visit a medical facility. On the basis of these treatment characteristics, this class was categorized as the &#x201C;group of women under observation.&#x201D; Breast cancer was the most common cancer type (52/95, 54.7%), followed by gynecological cancers (19/95, 20%). In terms of cancer stage, more than half of the patients were classified as stage 1 (56/95, 58.9%). Of the 95 patients, recurrence was observed in 8 (8.4%) and metastasis in 4 (4.2%). Regarding employment status, 51 of 95 (53.7%) patients were employed. For information-seeking behavior, 43 of 95 (45.3%) patients answered, &#x201C;I do not use devices to gather information about cancer.&#x201D; Among those who gathered information, smartphones were used by 39 of 95 (41.1%) patients; however, overall, information-seeking behavior was limited compared with that of patients in the other classes.</p><p>Class 2 comprised 163 individuals, the majority of whom were male (141/163, 86.5%). Most patients in Class 2 were aged 60 years or older, with 144 of 163 (88.3%) patients in this range; 76 of 163 (46.6%) patients were aged 60&#x2010;69 years, and 68 of 163 (41.7%) patients were &#x2265;70 years. Regarding treatment status, 128 of 163 (78.5%) patients were under regular observation after completing treatment, while 35 of 163 (21.5%) were in the follow-up stage without requiring hospital visits. These features led to this class being categorized as the &#x201C;group of men under observation.&#x201D; The most common cancer was gastrointestinal cancer (69/163, 42.3%), followed by prostate cancer (29/163, 17.8%). Most cases were classified as early stage, with 76 of 163 (46.6%) patients at stage 1 and 37 of 163 (22.7%) patients at stage 2. Recurrence occurred in 21 of 163 (12.9%) patients, and metastasis occurred in 14 of 163 (8.6%) patients. These proportions were higher than those in Class 1 but lower than those in Class 3. Regarding employment, 92 of 163 (56.4%) patients were not employed. The device most commonly used for information seeking was a smartphone (104/163, 63.8%), and 31 of 163 (19%) patients answered &#x201C;I do not use devices to gather information about cancer&#x201D;; this proportion was lower than that among participants in the other classes.</p><p>Class 3 comprised 92 individuals, all of whom were undergoing treatment (92/92, 100%). There were 59 (64.1%) females and 33 (35.9%) males, with the majority aged between 50 and 69 years (50&#x2010;59 years: 25/92, 27.2% and 60&#x2010;69 years: 31/92, 33.7%). Breast cancer was the most common cancer (41/92, 44.6%), followed by gastrointestinal (10/92, 10.9%) and prostate cancers (10/92, 10.9%). This class had a higher proportion of advanced cancers, with stage 4 accounting for 25 of 92 (27.2%) patients. Recurrence was observed in 33 of 92 (35.9%) patients and metastasis in 37 of 92 (40.2%) patients. Both proportions were higher in Class 3 than in the other 2 classes. Regarding information-seeking behavior, 50 of 92 (54.4%) patients used smartphones, but 31 of 92 (33.7%) patients answered &#x201C;I do not use devices to gather information about cancer.&#x201D; Given these features, this class was defined as the &#x201C;group under treatment&#x201D; (<xref ref-type="fig" rid="figure2">Figure 2</xref> and <xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref>).</p><fig position="float" id="figure2"><label>Figure 2.</label><caption><p>Class-specific conditional probabilities of sociodemographic and clinical characteristics identified by latent class analysis.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="cancer_v12i1e79065_fig02.png"/></fig></sec><sec id="s3-6"><title>Results of the Comparison Among the 3 Groups</title><p>All results were obtained from post hoc analyses. Regarding &#x201C;use of hospital-recommended apps and services for counseling support and information gathering,&#x201D; no significant differences were found. As shown in <xref ref-type="fig" rid="figure3">Figure 3</xref>, regarding &#x201C;things I&#x2019;ve researched about cancer,&#x201D; the results revealed that &#x201C;information about other patients&#x201D; was significantly lower in Class 2 than in the other classes (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=12.22; <italic>P=</italic>.002, post hoc test: Class 1 &#x003E; Class 2; <italic>P</italic>=.009, and Class 2 &#x003C; Class 3; <italic>P</italic>=.001). Regarding &#x201C;life during treatment&#x201D; (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=7.22; <italic>P</italic>=.03 and post hoc test: Class 2 &#x003C; Class 3; <italic>P</italic>=.01), Class 3 was significantly higher than Class 2. Regarding &#x201C;sources of cancer information,&#x201D; &#x201C;Cancer Consultation Support Center&#x201D; (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=17.31; <italic>P</italic>&#x003C;.001 and post hoc test: Class 2 &#x003C; Class 3; <italic>P</italic>&#x003C;.001) and &#x201C;National Cancer Center website&#x201D; (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=7.59; <italic>P</italic>=.02 and post hoc test: Class 2 &#x003C; Class 3; <italic>P</italic>=.01) were significantly higher in Class 3 compared with Class 2. Regarding &#x201C;SNS and apps used to gather cancer information,&#x201D; &#x201C;Instagram&#x201D; (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=12.57; <italic>P</italic>=.002 and post hoc test: Class 2&#x003C; Class 3; <italic>P</italic>=.001) and &#x201C;X (Twitter)&#x201D; (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=9.55; <italic>P</italic>=.008 and post hoc test: Class 2 &#x003C; Class 3; <italic>P</italic>=.002) were significantly higher in Class 3 compared with Class 2. Regarding &#x201C;blog&#x201D; (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=5.82; <italic>P</italic>=.054), no significant differences were found between classes after the post hoc test. For &#x201C;benefits of using psychosocial support and information-gathering services recommended by health care institutions,&#x201D; regarding &#x201C;facilitate communication with doctors and medical staff&#x201D; (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=12.57; <italic>P</italic>=.02 and post hoc test: Class 1 &#x003C; Class 2; <italic>P</italic>=.006), Class 2 was significantly higher than Class 1 (<xref ref-type="fig" rid="figure3">Figure 3</xref> and <xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref>).</p><p>According to <xref ref-type="fig" rid="figure4">Figure 4</xref>, for &#x201C;Factor 1: difficulties in information seeking&#x201D; (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=11.9; <italic>P</italic>=.003 and post hoc test: Class 2 &#x003C; Class 3; <italic>P</italic>=.007), Class 3 showed a significantly higher value than Class 2. For &#x201C;Factor 3: evaluation of the relationship with the physician&#x201D; (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=12.2; <italic>P</italic>=.002 and post hoc test: Class 2 &#x003E; Class 3; <italic>P</italic>=.002), Class 2 had a significantly higher value than Class 3. For &#x201C;Factor 5: assessment of reliability of information from nonmedical institutions&#x201D; (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=12.3; <italic>P</italic>=.002 and post hoc test: Class 1 &#x003E; Class 2; <italic>P</italic>=.002), Class 1 showed a significantly higher score than Class 2. Regarding the TIPI-J, agreeableness (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=6.7; <italic>P</italic>=.04) and neuroticism (<italic>&#x03C7;</italic>&#x00B2;<sub>&#x2082;</sub>=8.8; <italic>P</italic>=.01) did not show significant differences after the post hoc test (<xref ref-type="fig" rid="figure4">Figure 4</xref> and <xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref>).</p><fig position="float" id="figure3"><label>Figure 3.</label><caption><p>Results of multiple comparison analysis using the independent chi-square and post hoc tests.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="cancer_v12i1e79065_fig03.png"/></fig><fig position="float" id="figure4"><label>Figure 4.</label><caption><p>Results of multiple comparison analysis using the Kruskal-Wallis test and the Wilcoxon rank-sum test.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="cancer_v12i1e79065_fig04.png"/></fig></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><sec id="s4-1"><title>Principal Findings</title><p>The results revealed that age distribution and cancer type composition among the respondents in this study were generally consistent with trends in Japan&#x2019;s national cancer statistics [<xref ref-type="bibr" rid="ref31">31</xref>]. In addition, more than 80% of respondents indicated that they would like to use psychosocial support services or apps if recommended by medical institutions. Furthermore, in the results of the LCA, the &#x201C;female under observation&#x201D; group showed a high level of trust in &#x201C;Factor 5: assessment of the reliability of information from nonmedical institutions,&#x201D; whereas the &#x201C;male under observation&#x201D; group was less proactive in gathering information but placed a high value on &#x201C;Factor 3: evaluation of the relationship with the physician&#x201D; and &#x201C;facilitate communication with doctors and medical staff,&#x201D; indicating that they prioritize relationships with health care professionals. The &#x201C;under treatment&#x201D; group was the most active in collecting information, frequently using &#x201C;information about other patients,&#x201D; &#x201C;life during treatment,&#x201D; &#x201C;Cancer Consultation Support Center,&#x201D; and &#x201C;National Cancer Center website.&#x201D; However, the &#x201C;Factor 1: difficulties in information seeking&#x201D; score was also high, suggesting that treatment status and gender may influence barriers to gathering information and differences in trusted sources.</p></sec><sec id="s4-2"><title>Comparison With Previous Work</title><p>This study suggests that integrating the 3 factors from the TPB (ie, &#x201C;attitude,&#x201D; &#x201C;subjective norms,&#x201D; and &#x201C;perceived behavioral control&#x201D;) with the &#x201C;relationship function&#x201D; and &#x201C;task-oriented function&#x201D; from the patient-provider relationship model is associated with a stronger intention to use psychosocial support services and hospital-recommended apps. Within the TPB framework, hospital recommendations may consistently shape behavioral intentions as a form of subjective norm. Previous studies have also reported that recommendations from health care providers strongly influence information-seeking behavior and support service usage among patients with cancer [<xref ref-type="bibr" rid="ref51">51</xref>], and the results of this study are consistent with these findings.</p><p>Looking at each group, the male group under follow-up showed a high evaluation of their relationship with physicians and a strong trust in physician-provided information, with subjective norms in the TPB being particularly dependent on physicians. Previous research has also shown that male patients with cancer place a high value on trustworthiness and sincerity in their interactions with health care providers [<xref ref-type="bibr" rid="ref52">52</xref>]. Furthermore, in the male follow-up group, the relationship function based on trust in physicians appears to play a central role, possibly serving as a prerequisite for accepting psychosocial support services and information provision.</p><p>In contrast, the female group under follow-up showed relatively higher trust in &#x201C;information from other patients&#x201D; and nonmedical sources, suggesting that peer-derived experiential knowledge plays an important role in forming attitudes in the TPB. Earlier studies, particularly those focusing on patients with breast cancer, have reported that peer support contributes to acquiring information and alleviating anxiety about recurrence [<xref ref-type="bibr" rid="ref53">53</xref>-<xref ref-type="bibr" rid="ref55">55</xref>], which is consistent with the current findings. For this group, it is also possible that task-oriented functions, such as managing uncertainty and decision support, are supplemented outside health care institutions. By providing opportunities for exchange with other patients or sharing experiential information, health care providers may help translate behavioral intentions into action.</p><p>The &#x201C;under treatment&#x201D; group displayed the highest level of active information-seeking behavior among the 3 groups, but also the greatest difficulty in seeking information. In terms of the TPB framework, while &#x201C;behavioral intention&#x201D; to seek information or use psychosocial services was high, &#x201C;perceived behavioral control&#x201D; appeared to be low. From the perspective of the patient-provider relationship model, it was suggested that the task-oriented functions for exchanging information and managing uncertainty, and the relationship functions providing reassurance and emotional support, may not be sufficiently aligned with patients&#x2019; needs. Survivors with cancer undergoing treatment have strong information needs and clear intentions to seek information but may lack sufficient self-efficacy to understand the information and make decisions, leading to increased difficulty. Prior studies have also reported that patients with cancer in advanced or treatment phases experience heightened anxiety from online information [<xref ref-type="bibr" rid="ref56">56</xref>], lack of social support beyond the internet, and negative treatment experiences [<xref ref-type="bibr" rid="ref57">57</xref>]. Such negative experiences can decrease patients with cancer&#x2019;s self-efficacy and trust in their digital skills, making information seeking a heavy burden. Therefore, for survivors with cancer undergoing treatment, clarifying reliable information sources and having health care providers organize and supplement information is crucial for alleviating the psychological burden associated with information-seeking.</p></sec><sec id="s4-3"><title>Strengths and Limitations</title><p>The strength of this study lies in its analysis of information-seeking behaviors of survivors with cancer and usage of psychosocial support services, grounded in the 3 components of TPB, as well as the communication functions of relationship-oriented and task-oriented functions in the patient-provider relationship model. By using EFA to identify factors and subsequently using LCA to classify multiple subgroups, this study systematically captured the behavioral intentions underlying information-seeking activities. This approach identified diverse needs among subgroups&#x2014;needs that are often difficult to capture by a simple comparison of attributes&#x2014;regarding trusted sources of information and communication tendencies among survivors with cancer. In particular, differences in the levels of trust in information sources between men and women during the follow-up period highlight the importance of personalized information provision, offering practical insights for future patient support service design. However, this study involved several limitations that should be considered. First, although the target sample size was achieved and trends were found to partially align with national cancer incidence statistics, the sampling was not stratified by age or cancer stage. Consequently, there was a bias toward survivors in stages 1 and 2, whereas the proportion of survivors in stages 3 and 4, or those who experienced recurrence or metastasis, was relatively low. Given the imbalances in cancer type, age group, and stage, caution is warranted regarding the generalization of the study findings to all survivors with cancer. Second, this was a cross-sectional study aimed primarily at identifying tendencies in types of information-seeking behaviors and thus cannot establish causal relationships related to various factors and backgrounds associated with each survey item. Detailed factor analyses and longitudinal studies are necessary to elucidate how information-seeking behaviors and perceptions evolve over time. Third, because this study focused on differences by treatment status and gender, socioeconomic factors such as income, education, and digital literacy were not included in the survey. However, these factors may also influence information-seeking behaviors and the use of support services, suggesting that future research should comprehensively examine these variables. Fourth, the questionnaire used in this study was developed on the basis of previous research and theoretical frameworks. However, because no formal pilot testing or test-retest reliability verification was conducted before the survey, the temporal stability of the measurement could not be assessed. This represents a limitation, and caution is required when interpreting the results. In the future, a comprehensive psychometric evaluation, including test-retest reliability and measurement invariance, will be necessary.</p></sec><sec id="s4-4"><title>Conclusions</title><p>This study clarified how information-seeking behaviors among survivors with cancer differ depending on treatment status and sex. By applying the TPB and patient-provider relationship models and using EFA, LCA, and multiple comparison analyses, we identified subgroups of patients with cancer with different behavioral characteristics. Our findings provide valuable insights for designing necessary approaches to promote personalized psychosocial support services and information provision for patients, as well as for improving the user interfaces of products and services that support patients psychologically and socially. Future research should focus on the realities of information provision and communication between patients with cancer and health care professionals, as they relate to individualized support for middle-aged and older survivors with cancer. Further exploration from multifaceted perspectives, including health care providers&#x2019; recognition of information delivery and patients&#x2019; acceptance of information, is expected to lead to the development and improvement of personalized and patient-centered communication approaches in the future.</p></sec></sec></body><back><ack><p>We thank Benjamin Knight and Sarina Iwabuchi from Edanz for editing a draft of this paper. The authors declare the use of generative artificial intelligence (GAI) in the research and writing process. According to the GAIDeT taxonomy, the following tasks were delegated to GAI tools under full human supervision: translation and quality assessment. The GAI tool used was Paperpal. Responsibility for the final paper lies entirely with the authors. GAI tools are not listed as authors and do not bear responsibility for the outcomes. The declaration was submitted by the authors.</p></ack><notes><sec><title>Funding</title><p>No external financial support or grants were received from any public, commercial, or not-for-profit entities for the research, authorship, or publication of this paper.</p></sec><sec><title>Data Availability</title><p>All data generated or analyzed during this study are included in this published paper and Multimedia Appendix 2.</p></sec></notes><fn-group><fn fn-type="con"><p>Conceptualization, investigation, formal analysis, visualization, and paper preparation were performed by MH. DK and KT were responsible for reviewing and editing.</p></fn><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">aBIC</term><def><p>adjusted Bayesian information criterion</p></def></def-item><def-item><term id="abb2">BIC</term><def><p>Bayesian information criterion</p></def></def-item><def-item><term id="abb3">cAIC</term><def><p>consistent Akaike information criterion</p></def></def-item><def-item><term id="abb4">CHERRIES</term><def><p>Checklist for Reporting Results of Internet E-Surveys</p></def></def-item><def-item><term id="abb5">EFA</term><def><p>exploratory factor analysis</p></def></def-item><def-item><term id="abb6">LCA</term><def><p>latent class analysis</p></def></def-item><def-item><term id="abb7">MAP</term><def><p>minimum average partial</p></def></def-item><def-item><term id="abb8">SNS</term><def><p>social networking service</p></def></def-item><def-item><term id="abb9">TIPI-J</term><def><p>Japanese version of the 10-item Personality Inventory</p></def></def-item><def-item><term id="abb10">TPB</term><def><p>theory of planned behavior</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="web"><article-title>Data visualization tools for exploring the global cancer burden in 2022</article-title><source>Global Cancer Observatory: Cancer Today</source><access-date>2025-09-17</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://gco.iarc.who.int/today">https://gco.iarc.who.int/today</ext-link></comment></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bray</surname><given-names>F</given-names> </name><name name-style="western"><surname>Laversanne</surname><given-names>M</given-names> </name><name name-style="western"><surname>Sung</surname><given-names>H</given-names> </name><etal/></person-group><article-title>Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>CA Cancer J Clin</source><year>2024</year><volume>74</volume><issue>3</issue><fpage>229</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.3322/caac.21834</pub-id><pub-id pub-id-type="medline">38572751</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>PT</given-names> </name><name name-style="western"><surname>Hori</surname><given-names>M</given-names> </name><name name-style="western"><surname>Matsuda</surname><given-names>T</given-names> </name><name name-style="western"><surname>Katanoda</surname><given-names>K</given-names> </name></person-group><article-title>Cancer prevalence projections in Japan and decomposition analysis of changes in Cancer burden, 2020-2050: a statistical modeling study</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2023</year><month>12</month><day>1</day><volume>32</volume><issue>12</issue><fpage>1756</fpage><lpage>1770</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-23-0754</pub-id><pub-id pub-id-type="medline">37756571</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mullan</surname><given-names>F</given-names> </name></person-group><article-title>Seasons of survival: reflections of a physician with cancer</article-title><source>N Engl J Med</source><year>1985</year><month>07</month><day>25</day><volume>313</volume><issue>4</issue><fpage>270</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1056/NEJM198507253130421</pub-id><pub-id pub-id-type="medline">4010738</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schouten</surname><given-names>B</given-names> </name><name name-style="western"><surname>Avau</surname><given-names>B</given-names> </name><name name-style="western"><surname>Bekkering</surname><given-names>GTE</given-names> </name><etal/></person-group><article-title>Systematic screening and assessment of psychosocial well-being and care needs of people with cancer</article-title><source>Cochrane Database Syst Rev</source><year>2019</year><month>03</month><day>26</day><volume>3</volume><issue>3</issue><fpage>CD012387</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD012387.pub2</pub-id><pub-id pub-id-type="medline">30909317</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goerling</surname><given-names>U</given-names> </name><name name-style="western"><surname>Faller</surname><given-names>H</given-names> </name><name name-style="western"><surname>Hornemann</surname><given-names>B</given-names> </name><etal/></person-group><article-title>Information needs in cancer patients across the disease trajectory. A prospective study</article-title><source>Patient Educ Couns</source><year>2020</year><month>01</month><volume>103</volume><issue>1</issue><fpage>120</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1016/j.pec.2019.08.011</pub-id><pub-id pub-id-type="medline">31474389</pub-id></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hack</surname><given-names>TF</given-names> </name><name name-style="western"><surname>Ruether</surname><given-names>JD</given-names> </name><name name-style="western"><surname>Pickles</surname><given-names>T</given-names> </name><name name-style="western"><surname>Bultz</surname><given-names>BD</given-names> </name><name name-style="western"><surname>Chateau</surname><given-names>D</given-names> </name><name name-style="western"><surname>Degner</surname><given-names>LF</given-names> </name></person-group><article-title>Behind closed doors II: systematic analysis of prostate cancer patients&#x2019; primary treatment consultations with radiation oncologists and predictors of satisfaction with communication</article-title><source>Psychooncology</source><year>2012</year><month>08</month><volume>21</volume><issue>8</issue><fpage>809</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1002/pon.1984</pub-id><pub-id pub-id-type="medline">21557385</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ha</surname><given-names>JF</given-names> </name><name name-style="western"><surname>Longnecker</surname><given-names>N</given-names> </name></person-group><article-title>Doctor-patient communication: a review</article-title><source>Ochsner J</source><year>2010</year><volume>10</volume><issue>1</issue><fpage>38</fpage><lpage>43</lpage><pub-id pub-id-type="medline">21603354</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X</given-names> </name><name name-style="western"><surname>Siu</surname><given-names>LL</given-names> </name></person-group><article-title>Impact of the media and the internet on oncology: survey of cancer patients and oncologists in Canada</article-title><source>J Clin Oncol</source><year>2001</year><month>12</month><day>1</day><volume>19</volume><issue>23</issue><fpage>4291</fpage><lpage>4297</lpage><pub-id pub-id-type="doi">10.1200/JCO.2001.19.23.4291</pub-id><pub-id pub-id-type="medline">11731511</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roach</surname><given-names>AR</given-names> </name><name name-style="western"><surname>Lykins</surname><given-names>ELB</given-names> </name><name name-style="western"><surname>Gochett</surname><given-names>CG</given-names> </name><name name-style="western"><surname>Brechting</surname><given-names>EH</given-names> </name><name name-style="western"><surname>Graue</surname><given-names>LO</given-names> </name><name name-style="western"><surname>Andrykowski</surname><given-names>MA</given-names> </name></person-group><article-title>Differences in cancer information-seeking behavior, preferences, and awareness between cancer survivors and healthy controls: a national, population-based survey</article-title><source>J Cancer Educ</source><year>2009</year><volume>24</volume><issue>1</issue><fpage>73</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1080/08858190802664784</pub-id><pub-id pub-id-type="medline">19259869</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osowiecka</surname><given-names>K</given-names> </name><name name-style="western"><surname>Ruci&#x0144;ska</surname><given-names>M</given-names> </name><name name-style="western"><surname>Abe</surname><given-names>T</given-names> </name><etal/></person-group><article-title>Cancer related information that cancer patients need</article-title><source>Sci Rep</source><year>2025</year><month>05</month><day>6</day><volume>15</volume><issue>1</issue><fpage>15811</fpage><pub-id pub-id-type="doi">10.1038/s41598-025-99498-4</pub-id><pub-id pub-id-type="medline">40328851</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blanch-Hartigan</surname><given-names>D</given-names> </name><name name-style="western"><surname>Chawla</surname><given-names>N</given-names> </name><name name-style="western"><surname>Moser</surname><given-names>RP</given-names> </name><name name-style="western"><surname>Finney Rutten</surname><given-names>LJ</given-names> </name><name name-style="western"><surname>Hesse</surname><given-names>BW</given-names> </name><name name-style="western"><surname>Arora</surname><given-names>NK</given-names> </name></person-group><article-title>Trends in cancer survivors&#x2019; experience of patient-centered communication: results from the Health Information National Trends Survey (HINTS)</article-title><source>J Cancer Surviv</source><year>2016</year><month>12</month><volume>10</volume><issue>6</issue><fpage>1067</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1007/s11764-016-0550-7</pub-id><pub-id pub-id-type="medline">27193357</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>P</given-names> </name><name name-style="western"><surname>Vargas</surname><given-names>A</given-names> </name><name name-style="western"><surname>N&#x00FA;&#x00F1;ez</surname><given-names>S</given-names> </name><name name-style="western"><surname>Macchiavello</surname><given-names>S</given-names> </name></person-group><article-title>A study of hospital complaints and the role of the doctor-patient communication</article-title><source>Revista m&#x00E9;dica de Chile</source><year>2011</year><month>07</month><volume>139</volume><issue>7</issue><fpage>880</fpage><lpage>885</lpage><pub-id pub-id-type="doi">10.4067/S0034-98872011000700008</pub-id><pub-id pub-id-type="medline">22051825</pub-id></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akbolat</surname><given-names>M</given-names> </name><name name-style="western"><surname>Amarat</surname><given-names>M</given-names> </name><name name-style="western"><surname>&#x00DC;nal</surname><given-names>&#x00D6;</given-names> </name><name name-style="western"><surname>&#x015E;anta&#x015F;</surname><given-names>G</given-names> </name></person-group><article-title>A survey of health information seeking by cancer patients indicates some problems over medical explanations and terminology</article-title><source>Health Info Libraries J</source><year>2023</year><month>03</month><volume>40</volume><issue>1</issue><fpage>29</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1111/hir.12387</pub-id></nlm-citation></ref><ref id="ref15"><label>15</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hack</surname><given-names>TF</given-names> </name><name name-style="western"><surname>Degner</surname><given-names>LF</given-names> </name><name name-style="western"><surname>Parker</surname><given-names>PA</given-names> </name><collab>SCRN Communication Team</collab></person-group><article-title>The communication goals and needs of cancer patients: a review</article-title><source>Psychooncology</source><year>2005</year><month>10</month><volume>14</volume><issue>10</issue><fpage>831</fpage><lpage>845</lpage><pub-id pub-id-type="doi">10.1002/pon.949</pub-id><pub-id pub-id-type="medline">16200519</pub-id></nlm-citation></ref><ref id="ref16"><label>16</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCormack</surname><given-names>LA</given-names> </name><name name-style="western"><surname>Treiman</surname><given-names>K</given-names> </name><name name-style="western"><surname>Rupert</surname><given-names>D</given-names> </name><etal/></person-group><article-title>Measuring patient-centered communication in cancer care: a literature review and the development of a systematic approach</article-title><source>Soc Sci Med</source><year>2011</year><month>04</month><volume>72</volume><issue>7</issue><fpage>1085</fpage><lpage>1095</lpage><pub-id pub-id-type="doi">10.1016/j.socscimed.2011.01.020</pub-id></nlm-citation></ref><ref id="ref17"><label>17</label><nlm-citation citation-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Hirayama</surname><given-names>M</given-names> </name><name name-style="western"><surname>Kasai</surname><given-names>D</given-names> </name><name name-style="western"><surname>Tabei</surname><given-names>K ichi</given-names> </name></person-group><article-title>Development of a behavioral model for the use of psychosocial support services by cancer survivors: a grounded theory pilot study</article-title><source>medRxiv</source><comment>Preprint posted online on  Jul 31, 2025</comment><pub-id pub-id-type="doi">10.1101/2025.07.31.25332471</pub-id></nlm-citation></ref><ref id="ref18"><label>18</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paul</surname><given-names>B</given-names> </name><name name-style="western"><surname>Kirubakaran</surname><given-names>R</given-names> </name><name name-style="western"><surname>Isaac</surname><given-names>R</given-names> </name><etal/></person-group><article-title>A systematic review of the theory of planned behaviour interventions for chronic diseases in low health-literacy settings</article-title><source>J Glob Health</source><year>2023</year><month>09</month><day>8</day><volume>13</volume><fpage>04079</fpage><pub-id pub-id-type="doi">10.7189/jogh.13.04079</pub-id><pub-id pub-id-type="medline">37681679</pub-id></nlm-citation></ref><ref id="ref19"><label>19</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ajzen</surname><given-names>I</given-names> </name></person-group><article-title>The theory of planned behavior</article-title><source>Organ Behav Hum Decis Process</source><year>1991</year><month>12</month><volume>50</volume><issue>2</issue><fpage>179</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/0749-5978(91)90020-T</pub-id></nlm-citation></ref><ref id="ref20"><label>20</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Ishikawa</surname><given-names>H</given-names> </name></person-group><source>Introduction to Health Communication for Healthcare Professionals</source><year>2022</year><publisher-name>Taishukan Shoten</publisher-name><pub-id pub-id-type="other">9784469268829</pub-id></nlm-citation></ref><ref id="ref21"><label>21</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Duggan</surname><given-names>A</given-names> </name><name name-style="western"><surname>Street Jr</surname><given-names>RL</given-names> </name></person-group><article-title>Interpersonal communication in health and illness</article-title><source>Health Behavior: Theory, Research, and Practice</source><year>2015</year><edition>5</edition><publisher-name>Jossey-Bass</publisher-name><fpage>243</fpage><lpage>267</lpage><pub-id pub-id-type="other">9781118628980</pub-id></nlm-citation></ref><ref id="ref22"><label>22</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niu</surname><given-names>Z</given-names> </name><name name-style="western"><surname>Bhurosy</surname><given-names>T</given-names> </name><name name-style="western"><surname>Heckman</surname><given-names>C</given-names> </name></person-group><article-title>Cancer survivors&#x2019; emotional well-being: roles of internet information seeking, patient-centered communication, and social support</article-title><source>J Health Commun</source><year>2021</year><month>07</month><day>3</day><volume>26</volume><issue>7</issue><fpage>514</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1080/10810730.2021.1966685</pub-id><pub-id pub-id-type="medline">34435927</pub-id></nlm-citation></ref><ref id="ref23"><label>23</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budenz</surname><given-names>A</given-names> </name><name name-style="western"><surname>Sleight</surname><given-names>AG</given-names> </name><name name-style="western"><surname>Klein</surname><given-names>WMP</given-names> </name></person-group><article-title>A qualitative study of online information-seeking preferences among cancer survivors</article-title><source>J Cancer Surviv</source><year>2022</year><month>08</month><volume>16</volume><issue>4</issue><fpage>892</fpage><lpage>903</lpage><pub-id pub-id-type="doi">10.1007/s11764-021-01082-y</pub-id><pub-id pub-id-type="medline">34505207</pub-id></nlm-citation></ref><ref id="ref24"><label>24</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elkefi</surname><given-names>S</given-names> </name><name name-style="western"><surname>Matthews</surname><given-names>AK</given-names> </name></person-group><article-title>Exploring health information-seeking behavior and information source preferences among a diverse sample of cancer survivors: implications for patient education</article-title><source>J Cancer Educ</source><year>2024</year><month>12</month><volume>39</volume><issue>6</issue><fpage>650</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1007/s13187-024-02448-3</pub-id><pub-id pub-id-type="medline">38807002</pub-id></nlm-citation></ref><ref id="ref25"><label>25</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eysenbach</surname><given-names>G</given-names> </name></person-group><article-title>Improving the quality of web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES)</article-title><source>J Med Internet Res</source><year>2004</year><month>09</month><day>29</day><volume>6</volume><issue>3</issue><fpage>e34</fpage><pub-id pub-id-type="doi">10.2196/jmir.6.3.e34</pub-id><pub-id pub-id-type="medline">15471760</pub-id></nlm-citation></ref><ref id="ref26"><label>26</label><nlm-citation citation-type="web"><article-title>AstraZeneca conducted a web-based survey on ovarian cancer to understand how ovarian cancer patients gather information and to grasp the general public's awareness and understanding of ovarian cancer</article-title><source>AstraZeneca</source><year>2021</year><access-date>2025-04-24</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.astrazeneca.co.jp/news/press-releases1/2021/2021102101.html#">https://www.astrazeneca.co.jp/news/press-releases1/2021/2021102101.html#</ext-link></comment></nlm-citation></ref><ref id="ref27"><label>27</label><nlm-citation citation-type="report"><article-title>Patient Experience Survey, FY2023</article-title><year>2024</year><access-date>2025-04-24</access-date><publisher-name>National Cancer Center Japan</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="https://www.ncc.go.jp/jp/icc/policy-evaluation/project/010/2023/index.html">https://www.ncc.go.jp/jp/icc/policy-evaluation/project/010/2023/index.html</ext-link></comment></nlm-citation></ref><ref id="ref28"><label>28</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oshio</surname><given-names>A</given-names> </name><name name-style="western"><surname>Abe</surname><given-names>S</given-names> </name><name name-style="western"><surname>Cutrone</surname><given-names>P</given-names> </name></person-group><article-title>Development, reliability, and validity of the Japanese Version of Ten Item Personality Inventory (TIPI-J)</article-title><source>Jpn J Personal</source><year>2012</year><volume>21</volume><issue>1</issue><fpage>40</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.2132/personality.21.40</pub-id></nlm-citation></ref><ref id="ref29"><label>29</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bunevicius</surname><given-names>A</given-names> </name></person-group><article-title>Personality traits, patient-centered health status and prognosis of brain tumor patients</article-title><source>J Neurooncol</source><year>2018</year><month>05</month><volume>137</volume><issue>3</issue><fpage>593</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1007/s11060-018-2751-6</pub-id><pub-id pub-id-type="medline">29327173</pub-id></nlm-citation></ref><ref id="ref30"><label>30</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glaser</surname><given-names>AW</given-names> </name><name name-style="western"><surname>Fraser</surname><given-names>LK</given-names> </name><name name-style="western"><surname>Corner</surname><given-names>J</given-names> </name><etal/></person-group><article-title>Patient-reported outcomes of cancer survivors in England 1-5 years after diagnosis: a cross-sectional survey</article-title><source>BMJ Open</source><year>2013</year><volume>3</volume><issue>4</issue><fpage>e002317</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2012-002317</pub-id><pub-id pub-id-type="medline">23578682</pub-id></nlm-citation></ref><ref id="ref31"><label>31</label><nlm-citation citation-type="web"><article-title>Projected cancer statistics</article-title><source>Cancer Information Service (Ganjoho)</source><year>2025</year><access-date>2026-01-14</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://ganjoho.jp/en/public/statistics/short_pred.html">https://ganjoho.jp/en/public/statistics/short_pred.html</ext-link></comment></nlm-citation></ref><ref id="ref32"><label>32</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nylund-Gibson</surname><given-names>K</given-names> </name><name name-style="western"><surname>Choi</surname><given-names>AY</given-names> </name></person-group><article-title>Ten frequently asked questions about latent class analysis</article-title><source>Transl Issues Psychol Sci</source><year>2018</year><volume>4</volume><issue>4</issue><fpage>440</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1037/tps0000176</pub-id></nlm-citation></ref><ref id="ref33"><label>33</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watkins</surname><given-names>MW</given-names> </name></person-group><article-title>Exploratory factor analysis: a guide to best practice</article-title><source>J Black Psychol</source><year>2018</year><month>04</month><volume>44</volume><issue>3</issue><fpage>219</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1177/0095798418771807</pub-id></nlm-citation></ref><ref id="ref34"><label>34</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bartlett</surname><given-names>MS</given-names> </name></person-group><article-title>A note on the multiplying factors for various &#x03C7;2 approximations</article-title><source>J Roy Statist Soc Ser B</source><year>1954</year><month>07</month><day>1</day><volume>16</volume><issue>2</issue><fpage>296</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1111/j.2517-6161.1954.tb00174.x</pub-id></nlm-citation></ref><ref id="ref35"><label>35</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaiser</surname><given-names>HF</given-names> </name></person-group><article-title>An index of factorial simplicity</article-title><source>Psychometrika</source><year>1974</year><month>03</month><volume>39</volume><issue>1</issue><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1007/BF02291575</pub-id></nlm-citation></ref><ref id="ref36"><label>36</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Velicer</surname><given-names>WF</given-names> </name></person-group><article-title>Determining the number of components from the matrix of partial correlations</article-title><source>Psychometrika</source><year>1976</year><month>09</month><volume>41</volume><issue>3</issue><fpage>321</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1007/BF02293557</pub-id></nlm-citation></ref><ref id="ref37"><label>37</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mardia</surname><given-names>KV</given-names> </name></person-group><article-title>Measures of multivariate skewness and kurtosis with applications</article-title><source>Biometrika</source><year>1970</year><volume>57</volume><issue>3</issue><fpage>519</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1093/biomet/57.3.519</pub-id></nlm-citation></ref><ref id="ref38"><label>38</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Bandalos</surname><given-names>DL</given-names> </name><name name-style="western"><surname>Gerstner</surname><given-names>JJ</given-names> </name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Schweizer</surname><given-names>K</given-names> </name><name name-style="western"><surname>DiStefano</surname><given-names>C</given-names> </name></person-group><article-title>Using factor analysis in test construction</article-title><source>Principles and Methods of Test Construction: Standards and Recent Advances</source><year>2016</year><publisher-name>Hogrefe Publishing</publisher-name><fpage>26</fpage><lpage>51</lpage><pub-id pub-id-type="other">9781613344491</pub-id></nlm-citation></ref><ref id="ref39"><label>39</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lloret</surname><given-names>S</given-names> </name><name name-style="western"><surname>Ferreres</surname><given-names>A</given-names> </name><name name-style="western"><surname>Hern&#x00E1;ndez</surname><given-names>A</given-names> </name><name name-style="western"><surname>Tom&#x00E1;s</surname><given-names>I</given-names> </name></person-group><article-title>Exploratory factor analysis of the items: analysis guided by empirical data and software</article-title><source>Anales de Psicologia</source><year>2017</year><volume>33</volume><issue>2</issue><fpage>417</fpage><pub-id pub-id-type="doi">10.6018/analesps.33.2.270211</pub-id></nlm-citation></ref><ref id="ref40"><label>40</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Child</surname><given-names>D</given-names> </name></person-group><source>The Essentials of Factor Analysis</source><year>2006</year><edition>3</edition><publisher-name>Continuum</publisher-name><pub-id pub-id-type="other">9780826480002</pub-id></nlm-citation></ref><ref id="ref41"><label>41</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Norman</surname><given-names>GR</given-names> </name><name name-style="western"><surname>Streiner</surname><given-names>DL</given-names> </name></person-group><source>Biostatistics: The Bare Essentials</source><year>2014</year><edition>4</edition><publisher-name>People&#x2019;s Medical Publishing House</publisher-name><pub-id pub-id-type="other">&#x200E; 9781607951780</pub-id></nlm-citation></ref><ref id="ref42"><label>42</label><nlm-citation citation-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Jaju</surname><given-names>A</given-names> </name><name name-style="western"><surname>Crask</surname><given-names>MR</given-names> </name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Menon</surname><given-names>A</given-names> </name><name name-style="western"><surname>Sharma</surname><given-names>A</given-names> </name></person-group><article-title>The perfect design: optimization between reliability, validity, redundancy in scale items and response rates</article-title><year>1999</year><access-date>2026-05-20</access-date><conf-name>AMA Winter Educators&#x2019; Conference: Marketing Theory &#x0026; Application</conf-name><conf-loc>Chicago, IL</conf-loc><fpage>127</fpage><lpage>131</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://www.proquest.com/openview/b26e21dd92211bec765015f5be8dab4a/1?pq-origsite=gscholar&#x0026;cbl=35292">https://www.proquest.com/openview/b26e21dd92211bec765015f5be8dab4a/1?pq-origsite=gscholar&#x0026;cbl=35292</ext-link></comment></nlm-citation></ref><ref id="ref43"><label>43</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayes</surname><given-names>AF</given-names> </name><name name-style="western"><surname>Coutts</surname><given-names>JJ</given-names> </name></person-group><article-title>Use Omega rather than Cronbach&#x2019;s alpha for estimating reliability. but&#x2026;</article-title><source>Commun Methods Meas</source><year>2020</year><month>01</month><day>2</day><volume>14</volume><issue>1</issue><fpage>1</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1080/19312458.2020.1718629</pub-id></nlm-citation></ref><ref id="ref44"><label>44</label><nlm-citation citation-type="web"><article-title>Psych: procedures for psychological, psychometric, and personality research</article-title><source>CRAN (Comprehensive R Archive Network)</source><year>2025</year><access-date>2026-05-20</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/psych/index.html">https://cran.r-project.org/web/packages/psych/index.html</ext-link></comment></nlm-citation></ref><ref id="ref45"><label>45</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Hagenaars</surname><given-names>JA</given-names> </name><name name-style="western"><surname>McCutcheon</surname><given-names>AL</given-names> </name></person-group><source>Applied Latent Class Analysis</source><year>2002</year><publisher-name>Cambridge University Press</publisher-name><pub-id pub-id-type="doi">10.1017/CBO9780511499531</pub-id></nlm-citation></ref><ref id="ref46"><label>46</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwon</surname><given-names>JY</given-names> </name><name name-style="western"><surname>Johnson</surname><given-names>KL</given-names> </name><name name-style="western"><surname>Haase</surname><given-names>KR</given-names> </name><name name-style="western"><surname>Newton</surname><given-names>L</given-names> </name><name name-style="western"><surname>Fitch</surname><given-names>M</given-names> </name><name name-style="western"><surname>Sawatzky</surname><given-names>R</given-names> </name></person-group><article-title>Patterns of social support among older adults with cancer and associations with patient-reported outcomes: a latent class analysis</article-title><source>J Geriatr Oncol</source><year>2025</year><month>01</month><volume>16</volume><issue>1</issue><fpage>102157</fpage><pub-id pub-id-type="doi">10.1016/j.jgo.2024.102157</pub-id><pub-id pub-id-type="medline">39616862</pub-id></nlm-citation></ref><ref id="ref47"><label>47</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weller</surname><given-names>BE</given-names> </name><name name-style="western"><surname>Bowen</surname><given-names>NK</given-names> </name><name name-style="western"><surname>Faubert</surname><given-names>SJ</given-names> </name></person-group><article-title>Latent class analysis: a guide to best practice</article-title><source>J Black Psychol</source><year>2020</year><month>05</month><volume>46</volume><issue>4</issue><fpage>287</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1177/0095798420930932</pub-id></nlm-citation></ref><ref id="ref48"><label>48</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muth&#x00E9;n</surname><given-names>LK</given-names> </name><name name-style="western"><surname>Muth&#x00E9;n</surname><given-names>BO</given-names> </name></person-group><article-title>How to use a Monte Carlo study to decide on sample size and determine power</article-title><source>Struct Equ Modeling</source><year>2002</year><month>10</month><volume>9</volume><issue>4</issue><fpage>599</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1207/S15328007SEM0904_8</pub-id></nlm-citation></ref><ref id="ref49"><label>49</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linzer</surname><given-names>DA</given-names> </name><name name-style="western"><surname>Lewis</surname><given-names>JB</given-names> </name></person-group><article-title>poLCA: an R package for polytomous variable latent class analysis</article-title><source>J Stat Softw</source><year>2011</year><volume>42</volume><issue>10</issue><fpage>1</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.18637/jss.v042.i10</pub-id></nlm-citation></ref><ref id="ref50"><label>50</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shapiro</surname><given-names>SS</given-names> </name><name name-style="western"><surname>Wilk</surname><given-names>MB</given-names> </name></person-group><article-title>An analysis of variance test for normality (complete samples)</article-title><source>Biometrika</source><year>1965</year><month>12</month><volume>52</volume><issue>3/4</issue><fpage>591</fpage><pub-id pub-id-type="doi">10.2307/2333709</pub-id></nlm-citation></ref><ref id="ref51"><label>51</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chua</surname><given-names>GP</given-names> </name><name name-style="western"><surname>Tan</surname><given-names>HK</given-names> </name><name name-style="western"><surname>Gandhi</surname><given-names>M</given-names> </name></person-group><article-title>Information sources and online information seeking behaviours of cancer patients in Singapore</article-title><source>Ecancermedicalscience</source><year>2018</year><volume>12</volume><fpage>880</fpage><pub-id pub-id-type="doi">10.3332/ecancer.2018.880</pub-id><pub-id pub-id-type="medline">30483360</pub-id></nlm-citation></ref><ref id="ref52"><label>52</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kandasamy</surname><given-names>S</given-names> </name><name name-style="western"><surname>Khalid</surname><given-names>AF</given-names> </name><name name-style="western"><surname>Majid</surname><given-names>U</given-names> </name><name name-style="western"><surname>Vanstone</surname><given-names>M</given-names> </name></person-group><article-title>Prostate cancer patient perspectives on the use of information in treatment decision-making: a systematic review and qualitative meta-synthesis</article-title><source>Ont Health Technol Assess Ser</source><year>2017</year><volume>17</volume><issue>7</issue><fpage>1</fpage><lpage>32</lpage><pub-id pub-id-type="medline">28572868</pub-id></nlm-citation></ref><ref id="ref53"><label>53</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghazavi-Khorasgani</surname><given-names>Z</given-names> </name><name name-style="western"><surname>Ashrafi-Rizi</surname><given-names>H</given-names> </name><name name-style="western"><surname>Mokarian</surname><given-names>F</given-names> </name><name name-style="western"><surname>Afshar</surname><given-names>M</given-names> </name></person-group><article-title>Health information seeking behavior of female breast cancer patients</article-title><source>J Educ Health Promot</source><year>2018</year><volume>7</volume><fpage>138</fpage><pub-id pub-id-type="doi">10.4103/jehp.jehp_17_18</pub-id><pub-id pub-id-type="medline">30596110</pub-id></nlm-citation></ref><ref id="ref54"><label>54</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahsavar</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Choudhury</surname><given-names>A</given-names> </name></person-group><article-title>Examining influential factors in newly diagnosed cancer patients and survivors: emphasizing distress, self-care ability, peer support, health perception, daily life activity, and the role of time since diagnosis</article-title><source>PLoS One</source><year>2023</year><volume>18</volume><issue>9</issue><fpage>e0291064</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0291064</pub-id><pub-id pub-id-type="medline">37656716</pub-id></nlm-citation></ref><ref id="ref55"><label>55</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruiz-Romeo</surname><given-names>M</given-names> </name><name name-style="western"><surname>Ciria-Suarez</surname><given-names>L</given-names> </name><name name-style="western"><surname>Medina</surname><given-names>JC</given-names> </name><etal/></person-group><article-title>Empowerment among breast cancer survivors using an online peer support community</article-title><source>Support Care Cancer</source><year>2024</year><month>12</month><day>28</day><volume>33</volume><issue>1</issue><fpage>56</fpage><pub-id pub-id-type="doi">10.1007/s00520-024-09119-5</pub-id><pub-id pub-id-type="medline">39730856</pub-id></nlm-citation></ref><ref id="ref56"><label>56</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yli-Uotila</surname><given-names>T</given-names> </name><name name-style="western"><surname>Rantanen</surname><given-names>A</given-names> </name><name name-style="western"><surname>Suominen</surname><given-names>T</given-names> </name></person-group><article-title>Motives of cancer patients for using the Internet to seek social support</article-title><source>Eur J Cancer Care (Engl)</source><year>2013</year><month>03</month><volume>22</volume><issue>2</issue><fpage>261</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1111/ecc.12025</pub-id><pub-id pub-id-type="medline">23320398</pub-id></nlm-citation></ref><ref id="ref57"><label>57</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferraris</surname><given-names>G</given-names> </name><name name-style="western"><surname>Monzani</surname><given-names>D</given-names> </name><name name-style="western"><surname>Coppini</surname><given-names>V</given-names> </name><etal/></person-group><article-title>Barriers to and facilitators of online health information-seeking behaviours among cancer patients: a systematic review</article-title><source>Digit Health</source><year>2023</year><volume>9</volume><fpage>20552076231210663</fpage><pub-id pub-id-type="doi">10.1177/20552076231210663</pub-id><pub-id pub-id-type="medline">38107979</pub-id></nlm-citation></ref></ref-list><app-group><supplementary-material id="app1"><label>Multimedia Appendix 1</label><p>Questionnaire survey form.</p><media xlink:href="cancer_v12i1e79065_app1.docx" xlink:title="DOCX File, 1589 KB"/></supplementary-material><supplementary-material id="app2"><label>Multimedia Appendix 2</label><p>Datasets generated and analyzed during the study.</p><media xlink:href="cancer_v12i1e79065_app2.xlsx" xlink:title="XLSX File, 64 KB"/></supplementary-material><supplementary-material id="app3"><label>Checklist 1</label><p>CHERRIES checklist.</p><media xlink:href="cancer_v12i1e79065_app3.docx" xlink:title="DOCX File, 23 KB"/></supplementary-material></app-group></back></article>